How many investments has F-Prime Capital made?

F-Prime Capital has 459 tracked investments, 82 of which have exited, including 49 dated in the last 24 months.

What stage does F-Prime Capital invest at?

F-Prime Capital invests at the Pre-Seed, Seed, Series A, Series B, Series C stages.

What is F-Prime Capital's typical check size?

F-Prime Capital typically writes checks of $3M – $10M.

What sectors does F-Prime Capital focus on?

F-Prime Capital focuses on AI & Machine Learning, Biotech, Crypto & Web3, Deep Tech, Digital Health, Enterprise Software, Fintech, Healthtech, InsurTech, Medical Devices, Mental Health, SaaS, Sector Agnostic.

Where is F-Prime Capital located?

F-Prime Capital is headquartered in Cambridge, US.

Does F-Prime Capital lead rounds?

Yes, F-Prime Capital leads investment rounds.

Who does F-Prime Capital co-invest with?

F-Prime Capital most often shares deals with GV (Google Ventures), ARCH Venture Partners, Y Combinator, among 865 tracked co-investors.

F-Prime Capital

Venture capitaloperating company · company profile

Cambridge · Pre-Seed–Series C · 106 people tracked

Also known as Amazon · F-Prime · F-Prime Capital Partners · F-Prime Captial · IMPRESA MANAGEMENT LLC

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into F-Prime Capital

Paths you didn't know you had: your email and LinkedIn already hold routes to the F-Prime Capital team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict

Investment thesis

F-Prime backs founders across healthcare and technology with a preference for early-stage investing, though it will support exceptional teams at any stage. In healthcare, it focuses on therapeutics, medtech, and healthtech plus services in a stage-agnostic manner. In technology, it targets enterprise software, fintech, frontier tech, and crypto. The firm draws on a legacy spanning more than 50 years and a team of scientists, engineers, physicians, operators, and investors who bring real-world expertise to help companies accelerate toward scalable growth.

Source: firm website, verified Sep 27, 2026.

Leave your own feedback

Stage

Pre-Seed–Series C

Check

$3M – $10M

Cambridge, Massachusetts, US

Leads rounds

Leads

Instruments

Equity

Founded

2002

Last 12 months

26 investments

AUM

$13B

Tracked investments

459

Unicorns

IPOs

Acquisitions

Team · 106 people

from the firm's website & curated & public directories

Alex Pasteur· Partner· Londonin

Alex Pasteur joined F-Prime in 2012 as a London-based Partner focused on therapeutics and life sciences investments. He was a founding investor in ARTBIO, Tenpoint Therapeutics and Orchard Therapeutics, and has worked in healthcare investing since 2001, previously at MVM Life Science Partners. He holds an M.A. in Natural Sciences and a PhD in Chemistry, both from Cambridge University.

apasteur@fprimecapital.com

Brett Cook· Partner· Cambridgein

Brett Cook is a Partner at F-Prime focused on healthcare technology and services investments, having led or participated in deals including Iora Health, PatientPing, 1up Health, Equip, NOCD, and Proximie. He rejoined F-Prime in 2018 after leading finance at PatientPing and working at Aledade and McKinsey; he holds an MBA from Harvard and a BSE in Biomedical Engineering from Duke.

Carl Byers· Partner· Cambridgein 𝕏

Carl Byers is a Partner with deep operating experience in healthcare IT. He was on the founding team of athenahealth, serving as CFO from 1997 to 2010, where he built the firm's financial systems, led multiple financing rounds, and drove its 2007 IPO. He previously consulted at Booz, Allen & Hamilton and teaches finance at Harvard's Chan School of Public Health.

cbyers@fprimecapital.com

Chong Xu· Partner· Cambridgein

Chong Xu is a Partner at F-Prime focused on biopharmaceutical and medical technology, and collaborates with the Eight Roads Ventures Asia team on portfolio and investment opportunities in China. He joined F-Prime in 2015 after roles at McKinsey, hedge funds Massif Partners and Affirmed Healthcare, and neurobiology research at Temasek Life Sciences Laboratory; he holds a PhD in Cell Biology and an MBA from the University of Virginia and a biology degree from Zhejiang University.

David Jegen· Managing Partner, Tech Fund· Cambridgein 𝕏

David Jegen is Managing Partner of F-Prime's Tech Fund, investing at the intersection of fintech and enterprise software, with led investments including Flywire, Toast, Snapdocs, and Kensho. He previously co-founded Sensoria, held roles at Cisco, J.P. Morgan, and BCG, co-founded the nonprofit Fintech Sandbox in 2015, and holds a Harvard Law degree plus economics and accounting degrees from Indiana University.

djegen@fprimecapital.com

Gaurav Tuli· Partner· Boston, Massachusettsin

Jessica Alston· Partner· Boston, Massachusettsin

jalston@fprimecapital.com

Jon Lim· Managing Partner· Boston, Massachusettsin

Jon Lim is a Partner at F-Prime Capital Partners, where he leads venture and growth equity investments focused on healthtech and services companies through Fidelity's healthcare-focused venture fund.

jlim@fprimecapital.com

Ketan Patel· Managing Partner· Cambridge, Massachusettsin

kpatel@fprimecapital.com

M. Jackson Wilkinson· Venture and Operating Partner· Boston, Massachusetts, United Statesin

M. Jackson Wilkinson is a Venture and Operating Partner at F-Prime Capital, where he focuses on health technology. His background spans product, design, and engineering leadership, with an emphasis on healthcare-related technology and user experience.

Nihal Sinha· Partner· Londonin

nsinha@fprimecapital.com

Robert Weisskoff· Senior Partner· Massachusettsin

rweisskoff@fprimecapital.com

Rocio Wu· Partner· San Francisco Bay Areain

Rocio Wu is a Partner at F-Prime Capital, where she leads investments in Vertical AI, AI Infrastructure, and Fintech. Her early-stage investments include Fazeshift, Toku, Kanastra, Pie, Mercury, Together AI, Inworld, Overjet, and Chipper Cash. Prior to her investing career, she held operating roles in corporate development, go-to-market strategy, and growth at Google and Amazon across the United States, Japan, Spain, and China.

Sachin Patodia· Partner

Shervin Ghaemmaghami· Operating Partner· Cambridge, Massachusettsin 𝕏

Stephen Knight· President and Managing Partner· Cambridge, Massachusettsin

Stephen Knight is a Yale-trained MD/MBA physician-investor with Bell Labs and NIH roots and biotech operating experience who co-founds platform companies and works with academics to spin out science.

sknight@fprimecapital.com

Nihal Sinha, MB BChir· Partner

Abdul Abdirahman· Principal· Boston, Massachusettsin 𝕏

Abdul Abdirahman is a Principal at F-Prime Capital, concentrating on early-stage B2B software and fintech investments. Before F-Prime, he invested in emerging markets technology startups and worked with a venture-backed digital banking and payments startup in East Africa. He started his career in financial services, providing assurance and valuation work for venture capital, private equity, and hedge funds in New York and London, and holds B.A. and B.S. degrees from the University of Minnesota along with joint MBA and MPA/ID degrees from Stanford's Graduate School of Business and the Harvard Kennedy School.

Bala Varadhan· Principal· Cambridgein

Principal at F-Prime focused on early-stage crypto, blockchain, and Web3 investments. Previously worked at Avon Ventures and BCG on private equity due diligence and growth strategy, with earlier roles in private equity and law. Holds an MBA from Kellogg, a JD from Pritzker School of Law, and dual B.A.s from UT Austin.

Ben Gorman· Principal· San Franciscoin 𝕏

Principal at F-Prime focused on early-stage investments in enterprise software and AI. Previously a managing consultant at IBM working on data- and ML-driven go-to-market transformation, and a Carnegie Mellon graduate in Statistics and Economics.

Betsy Mulé· Principal· San Franciscoin 𝕏

Principal at F-Prime focused on early-stage investments in enterprise technology and robotics. Previously a strategy consultant at Mars & Co. advising Fortune 500 companies across the US, Latin America and Europe. Holds a degree in Chemical-Biological Engineering from MIT.

Brian Yordy· Principal· Cambridgein

Brian Yordy joined F-Prime in 2018 and focuses on biopharmaceutical and medical technology investments. He previously was an engagement manager at McKinsey and Company advising pharma and medtech companies, and holds a PhD in immunology from Yale and a B.S. in biochemistry from Notre Dame.

Connie Li· Principal· San Franciscoin

Connie Li is a Principal on F-Prime's life sciences team focused on biotechnology investments, and collaborates with the Eight Roads Ventures China team on F-Prime's China investments. She joined F-Prime in 2019, was involved in forming companies including K36 Tx, Skyline, Pediatrix, and AlphaGen, and previously worked as a consultant at IQVIA advising biopharma companies. She holds an MBA and MS from Harvard and a BSE in Bioengineering from the University of Pennsylvania.

Erica Lee· Principal· Cambridgein

Erica Lee is a Principal at F-Prime, where she focuses on investments in healthcare technology and services companies. She joined the firm in 2021 after working as an investment banking associate at Bank of America Merrill Lynch, advising on IPO and M&A transactions in healthcare IT. She holds a B.A. in Finance and International Business from Georgetown University.

Kevin Chu· Principal· San Francisco, Californiain

kchu@fprimecapital.com

Martin Taylor· Principal· Londonin

Martin Taylor is a Principal at F-Prime Capital focused on company building and early-stage venture capital investment in biotechnology. He has served on the founding or operational teams of five portfolio companies and holds particular interest in oncology, cardiovascular, renal, metabolic, and rare disease therapeutics. He holds a First Class BA and MSci from the University of Cambridge and a PhD from the Cancer Research UK London Research Institute and UCL, with an academic background in molecular biology, biochemistry, biophysics, and genetics.

mtaylor@fprimecapital.com

Nikhil Ananth· Principal· Boston, Massachusettsin 𝕏

Nikhil Marathe· Principal· Boston, Massachusetts, United Statesin

Nikhil Marathe is Principal and Head of Growth Equity at F-Prime, where he focuses on funding healthcare software and services businesses. He previously worked at Silversmith, TA Associates, and Evercore.

Allison MacLeod· Venture Partner· Cambridgein

Allison MacLeod is CMO of Flywire (Nasdaq: FLYW), where she leads global marketing and revenue operations and helped guide the company to its 2021 IPO. She has over 15 years of marketing experience, including roles at Rapid7 and Forrester, and advises early-stage companies.

Amber Cai· Venture Partner· Cambridge

Venture Partner at F-Prime focused on early-stage biotechnology investments, and founding CEO of gene and cell therapy company Skyline Therapeutics. She was previously a founding member and Head of Operations of Novartis' R&D Center in China, holds a PhD from MIT in GPCR signaling, and an MBA from MIT Sloan.

Bobby Gaspar· Venture Partner· Londonin

A physician-scientist with over 25 years in medicine and biotechnology, Bobby Gaspar is a Venture Partner at F-Prime based in London. He is a scientific founder and CEO of Orchard Therapeutics, a pioneer in hematopoietic stem cell gene therapy, chair of Eligo Biosciences, and an honorary professor of pediatrics and immunology at UCL Great Ormond Street Institute of Child Health.

Carlos Bustamante· Venture Partner· San Franciscoin

Carlos Bustamante joined F-Prime in January 2019 as a Venture Partner in the San Francisco office, focusing on applying data science and genomics to problems in medicine, agriculture, and biology. He is on leave from Stanford University, where he is a Professor of Biomedical Data Science, Genetics, and Biology, and has founded and directed multiple academic units and companies. He holds a PhD in Biology and MS in Statistics from Harvard University.

Catherine Stehman-Breen· Venture Partner· Cambridge

Venture Partner at F-Prime based in the Cambridge office, focused on new company creation, with over 30 years of medical and biopharmaceutical experience. She previously served as CEO of Chroma Medicine, CRDO at Obsidian Therapeutics, EIR at Atlas Venture, and CMO at Sarepta Therapeutics, and holds an MD from the University of Chicago and an MS in epidemiology from the University of Washington.

Eric Blatte· Venture Partner· Cambridge

Eric Blatte joined F-Prime Capital as a Venture Partner in 2021, where he focuses on executive leadership and go-to-market functions in technology and cybersecurity companies. He has founded and helped lead companies from startup to over $100 million in revenue, including RiskRecon (acquired by Mastercard), Trusteer (acquired by IBM), Imprivata (IPO), and Centra Software (IPO). He holds an undergraduate degree from the Wharton School at the University of Pennsylvania and an MBA from MIT Sloan.

Gordon Chen· Venture Partner

Hannah Arnold· Venture Partner· Cambridge, Massachusettsin 𝕏

Harlan Krumholz· Venture Partner

Jay Farber· Venture Partner· San Francisco, Californiain 𝕏

Jessica Chen· Venture Partner

John Vigeant· Venture Partner

Jon Gelsey· Venture Partner

Josh Feinblum· Venture Partner· Boston, Massachusettsin 𝕏

Julia McDowell· Venture Partner· Providence, Rhode Island, United Statesin

Julia McDowell is a Venture Partner at F-Prime Capital. She has worked as a healthcare investor and executive in both the private and public sectors, with experience in operations, strategy, and commercialization.

Michael Zheng· Venture Partner

Mihir Shah· Venture Partner

Muz Mansuri· Venture Partner· Concord, Massachusetts, United Statesin

Namandjé N. Bumpus· Venture Partner

Nicholas Haining· Venture Partner

Richard Pazdur· Venture Partner

Sam Bisbee· Venture Partner· Boston, Massachusettsin 𝕏

Sam Bisbee serves as Vice President of Information Security at DraftKings Inc. He has held senior technology and cybersecurity roles across multinational enterprises, startups, and B2B SaaS companies, and provides advisory services to enterprise leaders, investors, and startups.

Sandor Palfy· Venture Partner· Budapest, Hungaryin 𝕏

Sanjay Aggarwal· Venture Partner· Cambridge, Massachusettsin

Sanjay Aggarwal is a Venture Partner at F-Prime Capital who invests in early-stage physical AI and enterprise AI companies. He also works with portfolio companies operating in the India-US corridor.

Stacie Weninger· Venture Partner· Massachusettsin

Stephanie Robotham· Venture Partner

Muzammil Mansuri· Venture Partner

Nicholas Haining, BM, BCh· Venture Partner

Bettina Warburg· Venture Partner

Emma Carey· Marketing Manager

Mike Bertke· Associate

Tomesha Campbell· Executive Assistant

Abby Wagner· Senior Accountant· Cambridgein

Abby Wagner joined F-Prime Capital in September 2024 as a Senior Accountant. She previously worked as an Assurance Senior at Ernst & Young, LLP, focusing on private clients in the wealth and asset management industry. She holds an MBA and a BS in Accounting with a minor in Finance from Auburn University.

Allan Galper· Vice President & Associate General Counsel· Cambridge

Allan Galper serves as Vice President & Associate General Counsel at Fidelity Investments and supports F-Prime on legal matters spanning portfolio company investments and exits, fund formation, fund administration, and management company operations. He has over 25 years of legal experience across biotech, healthcare, software, and financial services, and previously was a partner at McCarter & English and an associate at Willkie Farr & Gallagher.

Andrew Bognanni· Director of Finance· Cambridge

Andrew Bognanni joined F-Prime in April 2022 to support the firm's finance and operations teams. He previously worked as a Manager at Standish Management and in the audit practice at RSM, and holds an M.S. in Accounting from Northeastern University.

Cathy Wong· Senior Director of Finance· Cambridgein

Cathy Wong joined F-Prime as Senior Director of Finance in July 2023, bringing over 14 years of accounting and finance experience. She previously served as a Controller at THL and held accounting and tax roles at Blackstone, Bain Capital, Bain & Company, and PwC. She holds a B.S. in Business Administration from Boston University and is a licensed CPA in Massachusetts.

Chance Mathisen· Associate· Cambridgein

Associate at F-Prime focused on early-stage enterprise software investments. Previously a consultant in Accenture's Software & Platforms Strategy practice, advising hyperscalers and technology companies on go-to-market and market expansion. Holds a B.S. in Managerial Economics from UC Davis.

Christine D'Attilio· Executive Assistant

Claire Knowlton· Marketing Associate· Cambridgein

Claire Knowlton joined F-Prime in 2025 as a Marketing Associate, supporting marketing through event planning and internal communications. She previously worked in email and social media marketing at an estate planning law firm and holds a BA in Marketing from Loyola University Chicago.

Clay Basser-Wall· Chief Compliance Officer· Cambridgein

Clay Basser-Wall is F-Prime's Chief Compliance Officer with over 20 years of legal and compliance experience. He joined F-Prime in 2020 after roles at Fidelity's Ethics Office, the U.S. SEC as an enforcement attorney, and law firms Wilson Sonsini and Brobeck Phleger & Harrison.

Crissy Derome· Executive Assistant· Cambridge

Crissy Derome joined F-Prime Capital in 2024, supporting the Crypto team, and serves as Project Coordinator for Fine Structure Ventures managing executive operations and scheduling. She previously held senior administrative roles at Fidelity Investments, Devonshire Investors, and Shields Health Care Group, and holds a Paralegal Studies degree from Eastern Nazarene College.

Davina Magargal· Head of Marketing· Cambridgein

Davina Magargal is F-Prime's Head of Marketing, overseeing brand strategy, communications, and marketing, with over 20 years in venture capital. She previously handled investor communications at Excel Venture Management and led marketing at Globespan Capital Partners and JAFCO Ventures, and holds a BA from Cedar Crest College.

Debbie Griffin· Chief Financial Officer· Cambridgein

Debbie Griffin is CFO at F-Prime with over 25 years of experience, overseeing finance and administration for Life Sciences and Fine Structure Ventures. She first joined F-Prime in 2013 for a decade in various finance roles, later served as CFO at Human Capital, and rejoined F-Prime in April 2026. She previously held accounting roles at Devonshire Investors, CFGI, and Ernst & Young.

Derrick Williams· Receptionist· Cambridgein

Derrick Williams is the Receptionist at F-Prime, joining in October 2018. He previously spent five years in security with Northeast Security and studied Computer Networking Operations at Gibbs College.

Eleni Russell· Senior Director of Finance· Cambridgein

Eleni Russell is Senior Director of Finance at F-Prime, which she joined in 2018, and has more than 15 years of experience in venture capital and private equity. She previously worked as an Accounting Manager at Fidelity Investments, overseeing venture capital and private equity entities within the Corporate Accounting group, and earlier as a senior accountant at TVM Capital. She holds a Bachelor of Science in Finance from Suffolk University.

Elizabeth Lamb· Executive Assistant· Cambridge

Elizabeth Lamb is an Executive Assistant at F-Prime Capital Partners, which she joined in July 2025 before moving into a full-time role in March 2026 supporting several members of the team. She previously held Executive Assistant positions at startups and pharmaceutical companies including Kura Oncology, GNS Healthcare, and Vertex, and spent 17 years in the Legal Department at Fidelity Investments. She earned an AS in Computer Programming and an AA in Liberal Arts from Keene State College.

Garth Rapeport· Entrepreneur-in-Residence

Grace Root· Director of Finance

Henry Trapnell· Director of Industry Networks· Birmingham, Alabama, United Statesin

Henry Trapnell is Director of Industry Networks at F-Prime Capital, where he leads a global community of executives and supports the firm's understanding of corporate strategic priorities in AI adoption, fintech, and enterprise software. He holds an MBA from Stanford and previously worked at Google and JP Morgan.

Jack Neureuter· Senior Associate· United Statesin

Jillian Enos· VP of Finance

Jingwei Li· Senior Associate· New York, New York, United States

John Shiver· Special Advisor

Joshua Gray· Vice President and Associate General Counsel· Boston, Massachusetts, United Statesin

Karen Roaf· Director of Human Resources

Kendra Ryan· Director of Ecosystem Network

Laura Wysk· Executive Assistant

Liam Maniscalco· Associate

Lisa Robidoux· Senior Accountant· Greater Bostonin

Lucia Del Guerzo· Office Manager

Megan Jenkins· Senior Director of Finance· Boston, Massachusetts, United Statesin

Megan Jenkins is Senior Director of Finance at F-Prime Capital, where her work covers financial analysis, strategic planning, and financial operations. Her experience includes fund financial reporting and valuations for venture capital and private equity firms, fund onboarding, investor communications, risk management, and compliance. She is a CPA and holds a Master's in Accounting/MBA and a Bachelor's degree in Mathematics.

Michelle Doerr· Director of Compliance and Risk· Arnold, Missouri, United States

Mike Feng· Head of Technology and Data Science· Cambridge, Massachusetts, United Statesin

Natasha Rodgers· Associate

Nicole Creighton· Human Resources Generalist

Olivia Carlson· Senior Associate· United Statesin

Rachel Feely-Kohl· Vice President, Community & Platform

Rachel Woolbert· Executive Assistant

Raj Basak· Senior Associate· Cambridge, Massachusetts, United Statesin

Raj Basak is a Senior Associate at F-Prime Capital, where he focuses on life sciences and healthcare investing. He previously worked in healthcare investment banking and consulting, and has a background in research.

Renée Beccia· Chief Financial Officer

Rosanne Yang· Senior Legal Counsel· United Statesin

Rosanne Yang is Senior Legal Counsel at F-Prime Capital, where she advises private equity and venture capital investors along with high-growth companies on transactions and other legal matters. Her work spans venture financings, mergers and acquisitions, capital markets, corporate governance, due diligence, and commercial agreements, with a focus on the technology and life sciences industries. She has held both in-house and law firm roles.

Rosy Howell· Executive Assistant· Washington, District of Columbia, United States

Sarah Alvarez· Executive Assistant

Sarah Lamont· Senior Associate· Boston, Massachusettsin 𝕏

Sarah Lamont is an investor at F-Prime focusing on early-stage fintech companies. She can be reached at slamont@fprimecapital.com.

Tenzin Jampa· Data Scientist· New York, New York, United Statesin

Tenzin Jampa is a Data Scientist at F-Prime and a graduate of MIT in Physics and Philosophy. As an undergraduate researcher, Jampa built a deep learning pipeline to classify particles from CERN LHCb collision data, developed benchmarking frameworks for semantic retrieval over physics literature, and created an open-source symbolic algebra library in Python, with additional work fine-tuning domain-specific language models such as PhysBERT and integrating knowledge graphs into Retrieval-Augmented Generation systems. Jampa also writes essays and hosts podcasts on technical and philosophical topics.

Thomas Beck· In Memoriam

Tierney Caputo· Executive Assistant

Natasha Rodgers, MB BChir· Associate

Founder mafia

The F-Prime Capital mafia →

11 people who came through F-Prime Capital went on to found or lead other companies.

Wei LiExecutive Partner - ChinaFounded Quantxbio +1 John RaguinVenture PartnerFounded Crunchtime +1 Miles LasaterVenture PartnerFounded SeeClickFix +1 Ben AuspitzPartnerFounded Dimension Therapeutics +1 David MouInternFounded Benchmarkhealth +1 Bobby GasparVenture PartnerFounded Orchard Therapeutics Carlos BustamanteVenture PartnerFounded Galatea Bio Josh FeinblumVenture PartnerFounded Stavvy Rodrigo PrudencioSenior AssociateFounded Shuddle Nate FoxVenture Summer AssociateFounded Ribbon Health Evan PowellInvestment Team MBA AssociateFounded Reprise

What they invest in

from 340 of 459 portfolio companies

Healthtech ×140Biotech ×118AI & Machine Learning ×86SaaS ×83Fintech ×79Digital Health ×77Medical Devices ×71Enterprise Software ×56

HQs:United States×209China×12India×12United Kingdom×10Mexico×5Switzerland×3

Who they back

founder profiles across 222 portfolio companies

32%

solo founders

71 of 222 mapped founding teams

41%

repeat founders

of 250 founders with career history

~4 yrs

old at investment

median across 119 dated deals

Founding team size:solo founder×712 founders×743 founders×394+ founders×38

Where their founders studiedfrom 234 founders with education data

Massachusetts Institute of Technology ×15Harvard University ×14The Wharton School ×12University of California, Berkeley ×12Harvard Business School ×8Stanford University ×7Cornell ×6Northwestern University ×6

What their founders studiedfrom 229 founders with field-of-study data

Computer Science ×61Engineering ×48Business & Management ×31Life Sciences ×31Economics ×23Finance & Accounting ×19Medicine ×19Physics ×17

Where their founders worked beforefrom 250 founders with career history

Google ×14Massachusetts General Hospital ×8IBM ×7Microsoft ×7Goldman Sachs ×6Bain & Company ×5ConsenSys ×5Yale University ×5

Accelerator rootsportfolio companies that came through a program

Y Combinator ×21 Techstars ×7

57 founders hold a PhD · 50 hold an MBA (of 244 with degree data) · backed the same founder in 2+ companies: 2 founders

Investments · 459 tracked

founders shown can be your intro path

By year:2026 · 17 2025 · 26 2024 · 25 2023 · 29 2022 · 22 2021 · 18 2020 · 13 2019 · 16 2018 · 16 2017 · 17 2016 · 10 2015 · 5225 dated

Caribou Biosciencescariboubio.com in 𝕏NASDAQ: CRBUMar 2021

Caribou Biosciences is a clinical-stage biopharmaceutical company developing CRISPR genome-editing therapies, including off-the-shelf CAR-T cell therapies for hematologic malignancies and armored cell therapies using its Cas12a chRDNA platform.

BiotechMedical DevicesBerkeley, US

Jennifer Doudna(Founder)Rachel Haurwitz(Founder)inMartin Jinek(Founder)Andrew May(Executive Officer)James Berger(Founder)

Board Jenny Rooke(Director)in

Board seat Robert Weisskoff· per SEC Form D

Co-investorsAliment Capital Avego BioScience Capital IA Seed Ventures LifeSci Venture Partners Mission Bay Capital Mission Biocapital +3 more

Neumora Therapeuticsneumoratx.com in 𝕏NASDAQ: NMRASeries A · Jan 2023 · $400M

Neumora is a clinical research company developing investigational medications, with a focus on conducting clinical trials to obtain regulatory approval and make treatments available to patients.

BiotechDeep TechDigital HealthMedical DevicesWatertown, US

Paul L. Berns(Chairman and Chief Executive Officer)Joshua Pinto(Executive Officer)Tamara Tompkins(Executive Officer)inKari Stefansson(Director)Maykin Ho(Director)Alaa Halawa(Director)

Board seat Stacie Weninger· per SEC Form D

Co-investorsARCH Venture Partners Catalio Capital Management, LP K2 HealthVentures Mercury Fund Premier Partners SoftBank Vision Fund +12 more

peerTransferNASDAQ: FLYWFeb 2020

Flywire operates a global payments platform and software company that processes high-value transactions for education, healthcare, travel, and business-to-business sectors, combining invoicing, settlement tools, and local payment methods across 240+ countries and 140+ currencies to help organizations optimize their accounts receivable functions.

Boston, US

Michael Massaro(Executive Officer, Director)Robert Orgel(President and Chief Operating Officer)Cosmin Pitigoi(Chief Financial Officer)Patrick Blanc(Chief Technology Officer)Peter Butterfield(General Counsel and Chief Compliance Officer)Mohit Kansal(Chief Payments Officer)

Board seat David Jegen· per SEC Form D

Co-investorsGoldman Sachs Kfund Spark Capital

ShouTi Inc.NASDAQ: GPCRJan 2022SEC filingmedium confidence

ShouTi Inc. is a clinical-stage biopharmaceutical company developing oral small molecule drugs targeting G-protein coupled receptors to treat chronic diseases including obesity, type 2 diabetes, and cardiovascular conditions.

BiotechSouth San Francisco, US

Raymond Stevens(Director)Ramy Farid(Director)Jessica Lifton(Director)Ting Xie(Director)Daniel Auerbach(Director)Cuiping Gu(Director)

Board seat Robert Weisskoff· per SEC Form D · $7M raise · filed Jan 2022

Co-investorsBiotechnology Value Fund

Xilio Therapeuticsxiliotx.com inNASDAQ: XLOJan 2021

Xilio Therapeutics is a clinical-stage biotechnology company developing masked immuno-oncology therapies that use protein engineering to remain inactive until activated by tumor-specific proteases within the tumor microenvironment.

BiotechHealthtechWaltham, US

René Russo(Executive Officer, Director)inJoseph Farmer(Executive Officer)Timothy Clackson(Executive Officer)Christopher Frankenfield(Chief Financial and Operating Officer)in Katarina Luptakova(Chief Medical Officer)inPaul Clancy(Director)

Board seat Robert Weisskoff· per SEC Form D

Co-investorsBain Capital Life Sciences Bay City Capital M Ventures MRL Ventures Fund RA Capital RiverVest Venture Partners +9 more

Aclaris Therapeuticsaclaristx.comNASDAQ: ACRSSeries A · Oct 2012 · $21M

Aclaris develops investigational monoclonal antibodies and small-molecule inhibitors targeting immune pathways for the treatment of atopic, autoimmune, and respiratory diseases.

BiotechHealthtechMedical DevicesWayne, US

Neal Walker(Executive Officer, Director)Kamil Ali-Jackson(Executive Officer)Stuart D. Shanler(Executive Officer)inJoseph Monahan(Executive Officer)in Hugh Davis(Executive Officer, Director)inJames Loerop(Executive Officer)

Co-investorsAisling Capital APERTURE Venture Partners Foresite Capital RA Capital Sofinnova Ventures Sofinnova Venture Partners +1 more

Adageneadagene.com inNASDAQ: ADAGJan 2020

Adagene is a clinical-stage immunotherapy company that uses computational biology and artificial intelligence to discover and design therapeutic antibodies for cancer treatment.

AI & Machine LearningBiotech

Co-investorsEight Roads Ventures Toba Capital General Atlantic

Adaptimmuneadaptimmune.com in 𝕏OTC: ADAPYSep 2014

Adaptimmune Therapeutics is a biotechnology company, though the specific focus of their therapeutic work is not detailed on this investors and media page.

BiotechHealthtechMedical DevicesAbingdon, Oxfordshire, US

James Noble(Chief Executive Officer)Adrian Rawcliffe(Chief Executive Officer and Director)in Gavin Wood(Chief Financial Officer)in William Bertrand(Chief Operating Officer)in John Lunger(Chief Patient Supply Officer)inElliot Norry(Chief Medical Officer)in

Co-investorsAvoro Capital Advisors Eight Roads Ventures Foresite Capital New Enterprise Associates (NEA)Ridgeback Capital

Avalyn Pharma Incavalynpharma.com inNASDAQ: AVLNSep 2023 · $175M

Avalyn Pharma develops inhaled therapies for pulmonary fibrosis, using a nebulization approach that delivers treatment directly to the lungs to reduce the tolerability problems of existing oral therapies.

BiotechHealthtech

Lyn Baranowski(CEO)in

Co-investorsAndera Partners Catalio Capital Management, LP InVivium Capital Norwest Venture Partners Pivotal Life Sciences RiverVest Venture Partners +9 more

Beam Therapeuticsbeamtx.com in 𝕏NASDAQ: BEAMNov 2018

Beam Therapeutics develops gene-editing medicines, particularly base editors and precision genome editing technologies, to create lifelong cures for patients with serious genetic diseases.

BiotechDeep TechMedical DevicesCambridge, US

David R. Liu(Founder)inJ. Keith Joung(Founder)inFeng Zhang(Founder)David R. Liu, Ph.D.(Founder and Inventor)J. Keith Joung, M.D., Ph.D.(Founder and Inventor)Feng Zhang, Ph.D.(Founder and Inventor)

Co-investorsARCH Venture Partners Dreamers VC Eight Roads Ventures Foresite Capital GV (Google Ventures)HongShan Capital Group +2 more

Bicara Therapeuticsbicara.com in 𝕏NASDAQ: BCAXSeries B · Mar 2023 · $110M

Bicara Therapeutics is a clinical-stage biopharmaceutical company developing bifunctional antibody therapies that combine tumor-targeting with immune-modulating payloads to treat solid tumors.

Ivan Hyep(Chief Financial Officer and Treasurer)inLara Meisner(Chief Legal Officer, Compliance Officer and Corporate Secretary)in David Raben(Chief Medical Officer)in

Co-investorsAisling Capital Eight Roads Ventures Foresite Capital Premji Invest RA Capital Red Tree Venture +6 more

Coherus Biosciencescoherus.com in 𝕏NASDAQ: CHRS

Coherus Oncology develops and commercializes immuno-oncology therapies, including the approved LOQTORZI, to treat patients with cancer.

BiotechHealthtechMedical DevicesRedwood City, US

Dennis M. Lanfear(Executive Officer, Director)Denny Lanfear(Founder)inAlan C. Herman(Executive Officer)inJean-Frederic Viret, Ph.D.(Executive Officer)Peter K. Watler, Ph.D.(Executive Officer)Barbara K Finck, M.D.(Executive Officer)

Co-investorsHEALTHCARE ROYALTY PARTNERS Sofinnova Ventures Venrock

Coinbasecoinbase.com in 𝕏Nasdaq: COIN

Coinbase is a cryptocurrency exchange platform that offers trading, custody, and financial services for cryptocurrencies, stocks, derivatives, and prediction markets to consumers, institutions, and developers.

Crypto & Web3FintechSan Francisco, US

Brian Armstrong(CEO)in Fred Ehrsam(Board Of Directors)in Emilie Choi(President & COO)in Alesia Haas(Chief Financial Officer)in Paul Grewal(Chief Legal Officer & Secretary)inLawrence (L.J.) Brock(Chief People Officer)

Co-investors1confirmation A.Capital Ventures a16z crypto Acrew Capital Adventure Fund Andreessen Horowitz +99 more

Compass Therapeuticscompasstherapeutics.com in 𝕏NASDAQ: CMPXSeries A · Dec 2017 · $49M

Compass Therapeutics uses proprietary antibody discovery platforms to generate and screen diverse panels of monoclonal and multispecific antibodies, aiming to identify synergistic therapeutic combinations.

BiotechHealthtechCambridge, US

Schuetz Thomas(Executive Officer, Director)in Errik Anderson(Executive Officer, Director)in Thomas J. Schuetz(Executive Officer, Director)in Vered Bisker-Leib(Executive Officer)inBarry Shin(Chief Financial Officer)in Neil Lerner(Senior Vice President, Chief Accounting Officer)in

Co-investorsAlumni Ventures BioBrit Foresite Capital GV (Google Ventures)OrbiMed venBio Partners +3 more

Cytek Biosciencescytekbio.com in 𝕏NASDAQ: CTKBOct 2020

Cytek Biosciences develops high-parametric analytical instruments and software that enable scientists at pharmaceutical companies, contract research organizations, and academic institutions to generate and analyze biological datasets.

BiotechDeep TechHardwareHealthtechMedical DevicesBellevue, US

Wenbin Jiang, Ph.D.(CEO and Chairman of the Board)Wenbin Jiang(Executive Officer, Director)inMing Yan, Ph.D.(Chief Technology Officer)Ming Yan(Executive Officer, Director)inJiecheng Zhang(Director)Allen Poirson(Director)

Co-investors3E Bioventures Capital Northern Light Venture Capital RA Capital

Denali Therapeuticsdenalitherapeutics.com inNASDAQ: DNLISeries A · Feb 2024 · $220M

Denali Therapeutics develops therapeutics for neurodegenerative diseases.

BiotechHealthtechMedical DevicesSan Francisco, US

Marc Tessier-Lavigne(Founder)inAlexander O. Schuth(Executive Officer)inRyan J. Watts(President, Chief Executive Officer and Director)inCarole Ho(Executive Officer)inSteve E. Krognes(Director)inAlexander Schuth(Founder)

Co-investorsARCH Venture Partners EcoR1 Capital Foresite Capital GV (Google Ventures)Flagship Pioneering Flagship Ventures

Flywireflywire.com in 𝕏NASDAQ: FLYW

Flywire is a global payments platform and software company that enables complex international payments across education, healthcare, travel, and B2B sectors.

Enterprise SoftwareFintechSaaSBoston, US

Iker Marcaide(Founder)in Mike Massaro(Founder)inMike Massaro (CEO)(Founder)

Partner David Jegen· led

Co-investors3Spoke Capital 500 Global Accel Bain Capital Ventures Balderton Capital Boston Seed Capital +10 more

Insmedinsmed.com in 𝕏NASDAQ: INSM

Insmed is a biopharmaceutical company that provides grants and charitable funding to support healthcare provider education and patient care initiatives focused on nontuberculous mycobacterial lung disease, non-cystic fibrosis bronchiectasis, and other serious lung diseases.

BiotechDigital HealthHealthtechMedical Devices

Will Lewis(Chair and Chief Executive Officer)inGeoffrey AllaninSara Bonstein(Chief Financial Officer)inRoger Adsett(Chief Operating Officer)Martina Flammer(Chief Medical Officer)in S. Nicole Schaeffer(Chief People Strategy Officer)in

Co-investorsBessemer Venture Partners Foresite Capital Hercules Capital, Inc.OrbiMed Prospect Venture Partners Ridgeback Capital +1 more

Pony.aipony.ai in 𝕏NASDAQ: PONY

Pony.ai develops autonomous driving technology and systems for multiple applications including robotaxis, robotrucks, and personally owned vehicles, serving both everyday mobility and commercial logistics markets.

AI & Machine LearningMobility & TransportationRoboticsSilicon Valley, US

James Peng(Founder)inTiancheng Lou(Founder)inJames Peng Tiancheng Lou(Founder)

Co-investors5Y Capital Comcast Ventures Comet Labs DCM Ventures HongShan Capital Group Teachers' Venture Growth +3 more

Precision BioSciencesprecisionbiosciences.com in 𝕏NASDAQ: DTIL

Precision BioSciences develops gene-editing medicines using its proprietary ARCUS genome editing platform, which employs sequence-specific nuclease enzymes to insert, remove, or repair DNA in living cells to treat hard-to-treat conditions including rare genetic diseases and hepatitis B (HBV).

BiotechDeep TechHealthtechDurham, US

MATTHEW KANE(Executive Officer, Director)Jeff Smith(Co-founder)in Derek Jantz(Co-founder)inTODD MELBY(Executive Officer)in Michael Amoroso(President, Chief Executive Officer)in

Board ROBERT ADELMAN(Director)

Co-investorsage1 Agent Capital Aliment Capital Brace Pharma OCV Partners OUP (Osage University Partners)+6 more

Prime Medicineprimemedicine.com in 𝕏NASDAQ: PRMESeries A · Oct 2019 · $120M

Prime Medicine develops one-time genetic therapies using Prime Editing, a gene editing technology developed in David R.

BiotechDeep TechHealthtechMedical Devices

Andrew Anzalone(Founder)in David Liu(Co-founder)in Allan Reine(Chief Executive Officer)in Mohammed Asmal(Chief Medical Officer)inAnn Lee(Chief Technical Officer)inSvetlana Makhni(Chief Financial Officer)in

Co-investorsARCH Venture Partners GV (Google Ventures)Newpath Partners OUP (Osage University Partners)Samsara BioCapital Arrive +1 more

Rallybio, LLCrallybio.com in 𝕏NASDAQ: RLYB

Rallybio is a clinical-stage biotech company developing therapies for people with severe and rare diseases, with a pipeline focused on complement dysregulation and hematology.

BiotechHealthtechNew Haven, US

Stephen Uden(Founder)inMartin W. Mackay(Chairman of the Board of Directors)inJon(Chief Financial Officer)

Co-investors5AM Ventures Canaan Partners Connecticut Innovations Mitsui Global Investment Pivotal Life Sciences Solasta Ventures +2 more

Toasttoasttab.com inNYSE: TOST

Toast provides a restaurant management platform combining point-of-sale hardware (Flex POS, Toast Go 3 handheld) with software tools for online ordering, payroll, and other operations.

FintechFoodTechRetail TechSaaSBoston, US

Stephen Fredette(Executive Officer, Director, Promoter)Jonathan Grimm(Founder)inAman Narang(Founder)inChristopher Comparato(Executive Officer, Director)Steve Fredette(Founder)

BoardSteve Papa(Director, Promoter)

Partner David Jegen· led

Co-investorsBessemer Venture Partners Blue Owl Capital Connetic Ventures Evolution VC Partners FIRSTFLOOR CAPITAL G2C Venture Partners +15 more

Unum Therapeuticscogentbio.com in 𝕏NASDAQ: COGT

Cogent Biosciences is a biotechnology company developing small molecule precision therapies for genetically driven diseases where the cause is linked to a specific genetic mutation.

BiotechDigital HealthHealthtechLongevityMedical DevicesCambridge, US

Charles Wilson(Executive Officer, Director)Christiana Stamoulis(Executive Officer)inAndrew Robbins(Chief Executive Officer, President and Director)inJohn Green(Chief Financial Officer)inEvan Kearns(Chief Legal Officer and Corporate Secretary)inCole Pinnow(Chief Commercial Officer)in

Co-investorsAtlas Venture Sanofi Ventures

Eywa Pharmaeywapharma.sgOct 2016 · $30M✓ verified

Eywa Pharma develops and manufactures generic drugs across multiple therapeutic areas and dosage forms, including tablets, capsules, and oral suspensions, for patients and pharmacies.

Advanced ManufacturingBiotechHealthtechMedical DevicesSingapore, SG

Board Ketan Patel(Director)in

Leyden Labsleydenlabs.com inSeries A · Mar 2021 · $47M✓ verified

Leyden Labs develops nasal sprays containing antibodies that target respiratory viruses such as influenza and COVID at the nasal mucosa to prevent initial infection and transmission.

BiotechDeep TechHealthtechLeiden, NL

Koenraad Wiedhaup(Founder & Chief Executive Officer)in Ronald Brus(Founder & Chief Growth Officer)inJaap Goudsmit(Founding Scientist and Senior Advisor)in Dinko Valerio(Founder and Chair of the Supervisory Board)in Jintanat Ananworanich(Chief Medical Officer)inClarissa Koch(Chief Scientific Officer)in

Co-investorsClavystBio GV (Google Ventures)Bluebird Ventures Byers Capital Casdin Capital European Innovation Council Fund +7 more

Nflection Therapeuticsnflection.com inJul 2023✓ verified

NFlection is a biopharmaceutical company developing novel therapeutics.

BiotechMedical DevicesBoston, US

Christopher Powala(Chief Development Officer, Former President & CEO)Mark de Souza(Executive Officer, Director)in

BoardCorey Goodman(Director)Ketan Patel(Director)in

Co-investorsvenBio Partners venBio Global Strategic

OrsoBioorsobio.com in 𝕏✓ verified

OrsoBio develops therapies to restore energy homeostasis in patients with severe metabolic disorders, drawing on biological research including human liver organoids and insights from metabolic pathways.

BiotechDeep TechMedical DevicesMenlo Park, US

Mani Subramanian(Executive Officer, Director)inGangadhara Ganapati(Executive Officer, Director)Dr. SubramanianDr. Myers

Board Matthew Young(Director)in Srinivas Akkaraju(Director)

Co-investorsAscenta Capital Longitude Capital Samsara BioCapital

1Uphealth1up.health in 𝕏Series B · Apr 2023 · $25M

1upHealth provides a FHIR-first health data platform that helps health plans and payers acquire, manage, and exchange healthcare data, including automating prior authorization, member data access, and provider directories.

Data & InfrastructureDigital HealthHealthtechBoston, US

Ritwik Sahu(Executive Officer, Director)Ricky Sahu(Founder)inJoseph Gagnon(Director)Andrew Boyd(Chief Executive Officer)in

Board Victor Echevarria(Director)inDavid Jegan(Director)

Board seat David Jegen· per SEC Form D

Co-investorsEniac Ventures Jackson Square Ventures Meridian Street Capital Sixth Street Social Leverage

Affinia Therapeuticsaffiniatx.com inSeries A · Oct 2025 · $60M

Affinia Therapeutics develops genetically engineered adeno-associated virus (AAV) therapies for treating genetic diseases, focusing initially on cardiovascular and central nervous system conditions.

AI & Machine LearningBiotechDeep TechWaltham, US

Luc Vandenberghe(Director)Aaron Tward, M.D., Ph.D.(Scientific Co-Founder)Botond Roska, M.D., Ph.D.(Scientific Co-Founder)Luk Vandenberghe, Ph.D.(Scientific Co-Founder and Adviser, and Board Member)Rami Daoud(Executive Officer)inRick Modi(Chief Executive Officer, Board Member)

Board seat Robert Weisskoff· per SEC Form D

Co-investorsAtlas Venture EcoR1 Capital Eight Roads Ventures GV (Google Ventures)New Enterprise Associates (NEA)TCG Crossover

Antlia Bioscience, Inc.antliabio.com inJun 2026SEC filingmedium confidence

Antlia Bioscience develops long-acting therapeutics aimed at treating chronic cardiometabolic diseases.

BiotechEncinitas, US

Brian Laurence Johnson(Executive Officer, Director)Ankit Mahadevia(Executive Officer, Director)

BoardBen Auspitz(Director)Carlos Garcia Echeverria(Director)

Board seat Martin Taylor Nihal Sinha· per SEC Form D · $20M raise · filed Jun 2026

Buoy Healthbuoyhealth.com in 𝕏Nov 2020

Buoy Health offers an AI-based symptom checker that asks users questions to help identify possible health issues and guides them toward appropriate care, products, or providers.

AI & Machine LearningDigital HealthHealthtechBoston, US

Andrew Le(Founder)inAdam Lathram(Executive Officer, Director, Promoter)Jose Eduardo Reyes(Director)Nathanael Yu Ren(Director)

Board seat Carl Byers· per SEC Form D

Co-investorsEvolution VC Partners Torch Capital FundRx Humana Optum Ventures Trustbridge Partners +1 more

CHARM Therapeuticscharmtx.com inSeries A · Apr 2023 · $50M

CHARM is a biotech company developing a next-generation menin inhibitor for acute myeloid leukemia (AML), designed to address resistance seen with first-generation approaches.

AI & Machine LearningBiotechHealthtechLondon

Lakshyaditya Singh Aithani(Executive Officer, Director)David Baker(Founder)Laksh Aithani(Founder)

Board Rishi Gupta(Director)in Muzammil Mansuri(Director)in

Board seat Muz Mansuri Nihal Sinha· per SEC Form D

Co-investorsNew Enterprise Associates (NEA)OrbiMed SR One Capital Management Axial VC Khosla Ventures NVentures

Checkmate Pharmaceuticalscheckmatepharma.comSeries B · Aug 2019 · $27MAcquired

Activating the immune system to recognize and destroy tumor cells.

BiotechCambridge, US

Art Krieg(Executive Officer, Director)Barry Labinger(Executive Officer, Director)Chuck Abdalian(Executive Officer)David Mauro(Executive Officer)Karen Brennan(Executive Officer)Charles Yon(Executive Officer)

Board seat Robert Weisskoff· per SEC Form D

Co-investorsDecheng Capital Longitude Capital Sofinnova Ventures Novo Holdings venBio Partners

Comanche Biopharmacomanchebiopharma.com inJan 2024 · $75M

Comanche Biopharma is a biopharmaceutical company developing an investigational siRNA medicine (CBP-4888) targeting a root cause of preterm preeclampsia in pregnant women.

BiotechFemTechHealthtechConcord, US

Mike Young(Founder)inT Scott Johnson(Founder)inPaul Antinori(Executive Officer)Allison August(Executive Officer)inThomas Scott Johnson(Executive Officer, Director)

Board Brendan Bulik-Sullivan(Director)in

Board seat Muz Mansuri Ketan Patel· per SEC Form D

Co-investorsAtlas Venture GV (Google Ventures)Broadview Ventures Lilly Asia Ventures New Enterprise Associates (NEA)

Ensomaensoma.comSeries A · Jan 2023 · $50M

Ensoma is a genomic medicine company developing a platform for in vivo engineering of hematopoietic stem cells (HSCs), combining an off-the-shelf delivery system with a gene engineering toolkit intended to treat diseases with a one-time treatment.

BiotechHealthtechMedical DevicesBoston, US

Albert Seymour(Director)

Board Kush Parmar(Executive Officer, Director)in Paula Soteropoulos(Director)

Board seat Stephen Knight· per SEC Form D

Co-investors5AM Ventures Aju IB Investment Catalio Capital Management, LP Delos Capital Solasta Ventures Viking Global +10 more

Generation Biogenerationbio.comFeb 2018SEC filingmedium confidence

BiotechCambridge, US

Geoff McDonoughy(Executive Officer, Director)Glenn Goddard(Executive Officer)Mark Angelino(Executive Officer)

Board Jason Rhodes(Director)inAnthony Quinn(Director)

Board seat Catherine Stehman-Breen· per SEC Form D · $100.4M raise · filed Mar 2018

Co-investorsAtlas Venture Foresite Capital Wellington Management Casdin Capital Deerfield Management Company Fidelity Investments +1 more

Notabenenotabene.id in 𝕏Series A · Jun 2026 · $10.2M

Notabene provides compliance and regulatory technology for crypto businesses and financial institutions, helping them meet regulatory requirements like the FATF Crypto Travel Rule through real-time screening, sanctions checks, and wallet identification.

Crypto & Web3CybersecurityEnterprise SoftwareFintechNew York City, US

Pelle Braendgaard(CEO)in Andres Junge(Founder)in Ania Lipinska(Founder)in Alice Nawfal(Founder)inCalvin K(Head of People Operations)Sacha Lowenthal(Head of Marketing)

Board seat David Jegen· per SEC Form D

Co-investorsBlockchain Coinvestors Digital Currency Group NextBlock ParaFi Capital Parafi General Fund Signature Ventures +17 more

OneAdvisoryoneadvisory.coJul 2025 · $8M

Dispatch is a data orchestration platform for the wealth advisory ecosystem that automatically syncs client data across disparate software tools and integrations.

AI & Machine LearningData & InfrastructureFintechSaaSMiami, US

Robert Nance(Executive Officer, Director, Promoter)Madalyn Armijo(Director, Promoter)

Board Chris Downer(Director)inRafi Lurie(Director)

Board seat David Jegen· per SEC Form D

Co-investorsExpa Great Oaks Venture Capital Brewer Lane Ventures CoFound Partners Venture Fika Ventures Ritholtz Wealth Management +2 more

Rarecyterarecyte.comJul 2023 · $24M

Seattle, US

Ronald Seubert(Executive Officer, Director, Promoter)Evan Castiglia(Executive Officer)in Joseph Victor(Executive Officer, Director)Frank Witney(Director)Eric Kaldjian(Executive Officer)

Board Robert Shepler(Director)in

Board seat Robert Weisskoff· per SEC Form D

Co-investors5AM Ventures Arboretum Ventures Telegraph Hill Partners HealthQuest Capital Sofinnova Ventures

Real Estate Equity Exchangeunisonim.comMay 2018SEC filingmedium confidence

Unison Investment Management (UnisonIM) is a registered investment adviser that builds and manages institutional equity and credit strategies giving exposure to U.S. residential housing and home price appreciation.

FintechPropTechSan Francisco, US

Thomas Sponholtz(Founder, CEO & Chairman)John Martinez(Director)Edgar Green(Director)James Riccitelli(Executive Officer, Director)Douglas H. Lowrey(Director)Matthew O'Hara(Chief Investment Officer)

Board seat David Jegen· per SEC Form D · $40M raise · filed Jun 2018

Snapdocssnapdocs.com in 𝕏Seed · May 2021

Snapdocs automates the digital mortgage closing process by connecting lending, settlement, and secondary market teams.

AI & Machine LearningFintechLegalTechPropTechSaaSPortland, US

Aaron King(CEO)inMatt Schindel(Executive Officer)Sanam Pangali(Executive Officer)Michael Sachdev(CEO)inNeel Palrecha(Vice President Engineering)in Peter Clark(Head of Product)in

Board seat David Jegen· per SEC Form D

Co-investors137 Ventures Accelerator Ventures Alkeon Innovation MetaProp MetaProp Ventures Red Swan Ventures +20 more

Tempest Therapeuticstempesttx.com inSeries B · Feb 2020 · $70M

Tempest Therapeutics is a clinical-stage biotechnology company developing in vivo CAR-T cell therapies for autoimmune and oncology indications.

BiotechHealthtechBrisbane, US

Stephen Brady(Director)inMatthew Angel(Executive Officer, Director)Nicholas Maestas(Executive Officer)inThomas W. Dubensky, Jr.(Executive Officer, Director)Thomas Woiwode(Director)Geoffrey Nichol(Director)

Board seat Robert Weisskoff· per SEC Form D

Co-investorsLAV Lilly Asia Ventures New Enterprise Associates (NEA)Quan Capital Roche Venture Fund Versant Ventures

Threat Stackthreatstack.com inSep 2017 · $45M

CybersecurityBoston, US

Jennifer M. Andre(Executive Officer)Dustin Webber(Director)Brian Ahern(Executive Officer, Director)in Doug Cahill(Executive Officer, Director)in

BoardChristopher P. Lynch(Director)Maria Cirino(Director)in

Board seat Gaurav Tuli· per SEC Form D

Co-investors.406 Ventures fama Ventures, LLC Scale Venture Partners Techstars Accomplice Eight Roads Ventures

Tradiertradier.com inSeries A · Apr 2023 · $24.6M

Tradier offers REST-based APIs and trading platforms providing equity, options, and futures trading, account management, market data, and brokerage services for individual developers and businesses.

FintechSaaSCharlotte, US

Dan Raju(Executive Officer, Director)in Peter Laptewicz(Executive Officer, Director)inRobert Kopple(Director)

BoardAlec Petro(Director)

Board seat David Jegen· per SEC Form D

Co-investorsDevonshire Investors

Tripsuitetripsuite.com inSeed · Sep 2024 · $5M

TripSuite is a software platform for travel agencies that combines CRM, commission tracking, accounting, itinerary management, analytics, and workflow automation in one system.

SaaSTravel & HospitalityBrooklyn, US

Jacey Jones(Executive Officer, Director, Promoter)inChristopher John Graves(Executive Officer, Director, Promoter)

Board seat Gaurav Tuli· per SEC Form D

Viewrayviewray.com in 𝕏Dec 2014

ViewRay develops MRIdian A3i, an MRI-guided radiation therapy system that uses diagnostic-quality MRI imaging for real-time tissue tracking and automated beam control during cancer treatment.

HardwareHealthtechMedical DevicesOakwood Village, US

James F. Dempsey(Executive Officer, Director)inDavid Chandler(Mr. Chandler is the Chief Financial Officer of the Issuer.)Chris A. Raanes(Executive Officer, Director)Michael Brandt(Executive Officer)D. David Chandler(Executive Officer)Gregory M. Ayers(President and Chief Executive Officer of the Issuer.)

Board seat Robert Weisskoff· per SEC Form D

Co-investorsAisling Capital Xeraya Capital OrbiMed

Zenflowzenflow.com in 𝕏Series B · Nov 2024 · $31.4M

Zenflow develops medical devices for treating benign prostatic hyperplasia (BPH) in men, founded from the Stanford Byers Center for Biodesign with a team experienced in medical device development and FDA regulation.

HealthtechMedical DevicesSan Francisco, US

Shreya Mehta(CTO)in Nick Damiano(CEO)inJohn Beck(Executive Officer)in

BoardBryan Kim(Director)Blayne Roeder(Director)

Board seat Robert Weisskoff· per SEC Form D

Co-investorsAstia CloudStone Capital Dorm Room ShangBay Capital LLC Y Combinator Agrolimen Ventures +15 more

Zus Healthzushealth.com in 𝕏Mar 2023

Zus provides a platform that removes data waste in healthcare, enabling developers, clinicians, and operators to innovate in patient and care team experience without building underlying infrastructure.

Cloud ComputingData & InfrastructureDigital HealthHealthtechWatertown, US

Jonathan Bush(CEO)inTravis Smith(Executive Officer)inJonathan S. Bush(Founder)

BoardSteven Fisher(Director)Fay Rotenberg(Director)Julie Yoo(Director)in

Board seat Carl Byers· per SEC Form D

Co-investorsAdvection Growth Capital Alumni Ventures Andreessen Horowitz JAZZ Venture Partners Martin Ventures Maverick Ventures +1 more

1Money1moneynetwork.com in 𝕏

1Money builds a decentralized payment network for stablecoin and tokenized deposit transfers, designed for global financial settlements.

Crypto & Web3Fintech

Matt Shroder(Founder)in Brian Shroder(Founder)inMatthew Shroder(Founder)

Co-investorsA100X Ventures CMT Digital Ventures Ethereal Ventures Management Ltd.Generative Ventures Hack VC Portage Ventures +5 more

3F Labs3f.xyz in 𝕏

3F is a DeFi protocol for leveraged strategies on tokenized real-world assets and onchain credit, letting users take leveraged exposure to RWA vaults or deposit stablecoins into Morpho-powered lending vaults to earn yield.

Crypto & Web3Fintech

Romeo Ravagnan(Founder)in

Co-investorsMaven 11 Gate Ventures GSR Metalayer

66 Nao66nao.com

脑动极光 (66nao) develops medical-grade digital therapeutics that combine brain science with AI to assess and treat cognitive impairment caused by vascular disease, neurodegenerative disease, psychiatric disorders, and childhood developmental deficits.

AI & Machine LearningDigital HealthHealthtechMental Health

蔡龙军(首席技术官兼首席运营官、代理首席执行官兼代理首席研发官 (CTO & COO, Acting CEO & Acting CRDO))王俊杰(首席财务官及联席公司秘书 (CFO & Joint Company Secretary))赖知远(市场及运营副总裁 (VP of Marketing and Operations))谭铮(董事会主席、执行董事兼首席战略官 (Chairman & Chief Strategy Officer))

ABio-Xabio-x.com in 𝕏

ABio-X is a life sciences incubation platform that creates and invests in biotech and pharmaceutical companies developing innovative medicines and technologies.

BiotechDeep TechHealthtechBoston, US

Co-investorsCBC Group

Abk Biomedical Incabkbiomedical.com in 𝕏Series B · Apr 2019 · $30M

ABK Biomedical is a clinical-stage medical device company that develops x-ray visible glass microspheres for Y-90 radioembolization and embolic treatment of cancers such as liver cancer.

BiotechHealthtechMedical DevicesHalifax, CA

Robert Abraham(Co-founder (Interventional Radiologist, MD))in Daniel Boyd(Co-founder (Material Scientist))in Sharon Kehoe(Co-founder (Material Scientist))in Anthony Headley(Executive Officer)in Gary Donofrio(Executive Officer)in Michael Mangano(Executive Officer, Director)in

Co-investorsEight Roads Ventures First Angel Network Association (FAN)Vivo Capital

Acacia Pharmaeagleus.com inSeries B · Sep 2013 · $24M

Eagle Pharmaceuticals develops and commercializes specialty pharmaceutical products for acute care and oncology, including injectable medications for procedural sedation, chemotherapy, lymphomas, and malignant hyperthermia management.

BiotechHealthtechMedical DevicesIndianapolis, US

Co-investorsGilde Healthcare

Adcentrx Therapeuticsadcentrx.com inApr 2023

Adcentrx Therapeutics is a biotech company focused on the discovery and clinical development of antibody-drug conjugates (ADCs) for oncology.

BiotechHealthtech

Hui Li(Founder, President & CEO)in

Co-investorsEight Roads Ventures Quan Capital Delta Capital

Adelaadelabio.com in 𝕏Series A · Jun 2021 · $60M

Adela develops blood-based tests for cancer detection using epigenetics and liquid biopsy technology, aimed at helping patients and clinicians detect and act on cancer earlier.

BiotechDigital HealthHealthtechMedical DevicesFoster City, US

Daniel Diniz De Carvalho(Executive Officer, Promoter)Scott Bratman(Executive Officer, Director)in Anne-Renee Hartman(Founder)inAlan Williams(Executive Officer)in Lisa Alderson(Executive Officer, Director)inPriscilla Huang(Executive Officer)in

Co-investorsDecheng Capital OrbiMed Deerfield Management Company Menlo Ventures

Aera Therapeuticsaeratx.com in 𝕏

Aera Therapeutics develops genetic medicines using next-generation delivery technologies and precision payloads optimized for specific diseases.

AI & Machine LearningBiotechDeep TechMedical DevicesCambridge, US

Feng Zhang, Ph.D.(Scientific Founder & Board Observer)Akin Akinc, Ph.D.(Chief Executive Officer & Board Director)Akin Akinc(Founder)Feng Zhang(Founder)Feng Zhang Akin Akinc(Founder)John Maraganore(Founder)

Co-investorsARCH Venture Partners Lux Capital GV (Google Ventures)JDRF T1D Fund Altitude Ventures Management, Llc Newpath Partners

Albert Inventalbertinvent.com inJun 2023

Albert provides an operating system for chemists that combines structured data management with AI trained on molecular structures and individual company chemistry datasets.

AI & Machine LearningDeep TechEnterprise Software

Zach Kisner(Co-founder)in Ken Kisner(Founder)in Nick Talken(Founder)in Neelesh Vaikhary(Co-founder)in Zack Kisner(Founder)in

Co-investorsBlue Trail Partners CapitalG Coatue Management Coral Capital Homebrew Index Ventures +2 more

Alderaskalder.com in

A senior care consulting firm serving Greater Boston families since 1993, offering life care management and aging support services with clinical expertise in geriatric social work.

Digital HealthHealthtechLongevityWellness & FitnessBoston, US

Kate Granigan(Clinical Leadership / Founder)in

Co-investorsHealthTrend Capital

Alfredalfredpay.io in 𝕏

Alfred Pay provides cross-border payment infrastructure for Latin America, offering virtual local bank accounts, instant multi-currency settlement, and a developer API.

Crypto & Web3FintechSaaS

Diego Yanez(Founder)in

Co-investorsDepartment of XYZ Digital Currency Group Rayo Capital Group Venture Dept.White Star Capital HOF Capital +4 more

Alibabaalibaba.com

Alibaba.com operates a global B2B e-commerce marketplace that connects buyers with suppliers and manufacturers for wholesale products across multiple industries.

AI & Machine LearningB2B MarketplacesE-commerce

Kuo ZhanginJack Ma(Founder)

Co-investorsAcross Capital Partners Eight Roads Ventures Granite Asia ICONIQ K2 Global Lead Edge Capital +8 more

Alkeon Capitalalkeon.comJul 2025

Alkeon is an investment firm that invests in growth-stage and innovative companies across their lifecycle, with a venture capital portfolio spanning multiple stages and industries.

Co-investorsAlkeon Innovation Accel Gaingels IVP (Institutional Venture Partners)Lachy Groom Tiger Global Management

Alluvial Financealluvial.financeAcquired

Staking software developer behind the enterprise liquid staking protocol Liquid Collective, acquired by Galaxy Digital in December 2025.

Chicago, US

Matthew R. Leisinger(Executive Officer, Director)Mara Schmiedt(Executive Officer, Director)Evan Weiss(Executive Officer)

BoardMin Teo(Director)

Co-investorsAmbush Capital Coinbase Ventures Fenbushi Capital Figment Nascent Variant Fund

Almanac Healthalmanac.chat in 𝕏Seed · Mar 2026 · $10M

Almanac Health is a clinical AI company that builds Almanac Chat, an evidence-based platform for clinical AI use by clinicians and health systems.

AI & Machine LearningDigital HealthHealthtechDover, US

Cyril Zakka(Executive Officer, Director)

Co-investorsGeneral Catalyst Lightspeed Venture Partners Soma Capital

Amber Therapeuticsamber-tx.com inSeries A · Jun 2024 · $100M

Amber Therapeutics develops medical technology focused on treating mixed urinary incontinence, advancing toward pivotal clinical trials in the US with expanded feasibility studies in Europe.

Medical Devices

Co-investorsIntuitive Ventures Lightstone Ventures New Enterprise Associates (NEA)Oxford Science Enterprises

Amphoraamphoralogistics.com inJul 2017 · $35.5M

Amphora provides logistics services aimed at supporting business growth and operational efficiency.

E-commerceLogistics & Supply ChainSaaS

Joan Tresserras(Founder)inAdrià Cortés(Founder)in

Co-investorsBStartup Longitude Capital Baird Capital HBM Healthcare Investments

AmplifyMDamplifymd.com inMar 2022 · $23M

AmplifyMD offers a virtual care platform with EHR integrations, automation, embedded AI tools, and a network of remote specialists that lets hospitals and health systems expand physician capacity and add specialty services.

AI & Machine LearningDigital HealthEnterprise SoftwareHealthtechSaaSLos Gatos, US

Anand Nathan(Founder)in Meena Mallipeddi(Founder)inMohan Mallipeddi, MD(Chief Medical Officer)inNijay Patel(Chief Technology Officer)in Kurt Blasena(Chief Commercial Officer)in

BoardStephen K. Klasko(Board of Directors)

Co-investorsForerunner Ventures Greylock Partners Tau Ventures TAU Ventures Memorial Hermann Health System

Apellis Pharmaceuticalsapellis.com in 𝕏acquired by Biogen · May 2026 · $5.6B

NASDAQ-listed company developing therapies for complement cascade-driven diseases in haematology, ophthalmology, and nephrology.

BiotechCrestwood, US

Pascal Deschatelets(Executive Officer)inCedric Francois(Executive Officer, Director)in

BoardGerald Chan(Director)Stephanie O'Brien(Director)Alec Machiels(Director)A. Sinclair Dunlop(Director)

Co-investorsAvoro Capital Advisors EMBL Ventures Epidarex Capital Keyhorse Capital Sofinnova Ventures Solasta Ventures +1 more

AppliedVRappliedvr.io in 𝕏Series A · Mar 2021 · $29M

AppliedVR develops immersive therapeutic software using technology to deliver drug-free clinical treatments for patients.

Digital HealthHealthtechMedical DevicesLos Angeles, US

Matthew Stoudt(Co-Founder and CEO)in Josh Sackman(Co-Founder and President)in

BoardDavid Sackman(Chairman)

Co-investorsEntrada Ventures JAZZ Venture Partners Magnetic Ventures Presence Capital Techstars GSR Ventures +1 more

AppsFlyerappsflyer.com in 𝕏

AppsFlyer's Measurement Suite provides marketing attribution, incrementality, revenue, and optimization measurement across mobile, web, CTV, and PC & console channels.

AdTechAI & Machine LearningData & InfrastructureMarketing TechSaaS

Oren Kaniel(Founder)inReshef Mann(Founder)inReshef Man(Founder)

Co-investors10D DTCP Magma Venture Partners Pitango Eight Roads Ventures General Atlantic +4 more

Apreo Healthapreohealth.com inAug 2025

Apreo Health develops a bronchoscopic treatment for severe emphysema using a self-expanding airway scaffold designed to reduce trapped air and improve lung function.

BiotechHealthtechMedical DevicesMenlo Park, US

Karun Durgam Naga(Executive Officer, Director)

BoardHanson S. Gifford III(Director)Zack Scott(Director)inMichael A. Carusi(Director)Drew Field(Director)in Dennis McWilliams(Director)in

Co-investorsIntuitive Ventures Lightstone Ventures Norwest Venture Partners Star51 Capital

Argyleargyle.com in 𝕏Jan 2022

Argyle provides a verification platform that automates the collection and verification of income, employment, and asset data using consumer-permissioned, real-time data from payroll, banking, and document sources.

Data & InfrastructureFintechNew York, US

Samuel Fishman(Executive Officer, Director, Promoter)Shmulik Fishman(Founder)in Daniel Yanisse(Director)inChristopher Hansen(Executive Officer, Director)Audrius Zujus(Founder)

Co-investorsBain Capital Ventures Mana Ventures Rackhouse Venture Management Lp SignalFire Stonewater Ventures C2 Ventures +2 more

Arion Cancer Hospitalarioncare.cn

Arion Care (美中爱瑞) is an oncology-focused hospital in China providing cancer diagnosis and treatment through multidisciplinary team (MDT) consultations and specialized centers for lung, breast, gastrointestinal, gynecologic, urologic, hepatobiliary, lymphoma, neurologic, and other cancers.

Digital HealthHealthtech

Arnatar Therapeuticsarnatar.com in 𝕏

Arnatar develops a next-generation RNA discovery platform called DARGER that combines gene silencing and gene upregulation technologies for oligonucleotide therapeutics.

AI & Machine LearningBiotechDeep Tech

Dr. Xuehai Liang(Founder)Dr. Yanfeng Wang(Founder & Chief Operating Officer)

Co-investors3E Bioventures Capital Apricot Capital Eight Roads Ventures Gaorong Ventures Legend Star New Alliance Capital

ARTBIOartbio.com in 𝕏Seed · Dec 2023 · $23M

ARTBIO develops alpha radioligand therapies (ARTs) for cancer treatment, designing target-and-molecule combinations intended to kill tumors while sparing healthy tissue.

BiotechHealthtechMedical DevicesOslo, NO

Roy Larsen(Scientific Co-Founder)Øyvind Bruland(Scientific Co-Founder; SAB Chairman)Margaret Yu(Chief Medical Officer)inPhilippe Dasse(Chief Technical Officer)inAmra Demirovic(Chief Human Resources Officer)inNicole Hadas(Chief Legal Officer)

Co-investorsB Capital Group B4 Capital Sofinnova Ventures Alexandria B Capital Omega Funds +2 more

Artemis Healthartemishealth.com in 𝕏Series B · Feb 2019 · $16M

Artemis Health provides data analytics and insights software to U.S. employers, advisors, and payers to optimize health benefits and reduce healthcare costs.

Data & InfrastructureEnterprise SoftwareHealthtechSalt Lake City, US

Grant Gordon(Executive Officer, Director)inDallen Allred(Executive Officer, Director)inDallin Regehr(Executive Officer)in

Board Dalton Wright(Director)in Jon Lim(Director)in Ambar Bhattacharyya(Director)

Co-investorsBessemer Venture Partners Kickstart Peterson Ventures Valence Ventures Maverick Ventures

Artemis Healthgetartemis.comMar 2019

Artemis is an AI-native security operations platform that builds a live model of an organization's environment across identity, cloud, endpoint, and SaaS to detect, investigate, and respond to attacks autonomously.

AI & Machine LearningCybersecurityEnterprise Software

Co-investorsValence Ventures Bessemer Venture Partners Maverick Capital Maverick Ventures Rose Park Advisors

Arvelle Therapeuticsangelinipharma.ch in

Angelini Pharma Switzerland is the Swiss arm of a pharmaceutical company focused on brain health and epilepsy, offering prescription treatments for patients and healthcare professionals.

BiotechConsumerHealthtechZug, CH

Co-investorsAndera Partners H.I.G. Capital H.I.G. HealthBridge Partners BRV Capital Management EQT Life Sciences H.I.G. BioHealth Partners

Ashbyashbyhq.com in 𝕏Series A

Ashby is a recruiting software platform that serves as an applicant tracking system (ATS) and all-in-one hiring management tool for talent teams.

Enterprise SoftwareHR TechSaaSSan Francisco, US

Benjamin Encz(Founder)in Abhik Pramanik(Recruiter)in Ghalib Suleiman(Software Engineer)inAaron Norby(Engineer)Colleen Gavaghen(Recruiter)Andy Brown(Engineer)

Co-investorsAlkeon Innovation DVC SemperVirens Venture Capital Todd and Rahul’s Angel Fund Trail Run Capital Y Combinator +13 more

Astraeusastraeuswealth.com in

Astraeus is an AI-native operating platform for wealth management firms that unifies data across a firm's fragmented systems into a single governed semantic layer and ontology.

AI & Machine LearningFintechSaaS

Asymmetry Financeasymmetry.finance 𝕏

Asymmetry Finance is a decentralized finance protocol that lets users borrow stablecoins (USDaf and AmpUSD) against BTC or stablecoin collateral at customizable fixed interest rates.

Crypto & Web3Fintech

Co-investorsMagnus Capital Silvermine Capital Avon Ventures Castle Island Ventures Ecco Capital gmjp +1 more

Atalantaatalantatx.com in 𝕏Series A · Jan 2021 · $110M

Atalanta is developing treatment options for intractable central nervous system diseases using RNA interference technology.

BiotechDeep TechHealthtechMedical Devices

Co-investorsNovartis Venture Fund RiverVest Venture Partners Sanofi Ventures abrdn plc EQT Life Sciences

AvantStayavantstay.com in 𝕏

AvantStay operates a collection of fully furnished, design-forward vacation rental homes in sought-after U.S. destinations, offering short- and long-term stays with amenities like concierge service, Wi-Fi, and smart locks.

B2B MarketplacesFuture of WorkMarketplacesPropTechTravel & HospitalityCulver City, US

Sean Breuner(Founder)in Reuben Doetsch(Executive Officer, Director, Promoter)in Jesse Suarez(Executive Officer)in Jodi Kessler(Director)in

BoardShawn Colo(Director)Eric Wiesen(Director)in

Co-investors3L Capital Abstract Ventures Alumni Ventures Blue Ivy Ventures Bullpen Capital Convivialité Ventures +10 more

AvenCellavencell.com in 𝕏Series B · Oct 2024 · $110M

AvenCell Therapeutics develops next-generation cell therapies for hard-to-treat cancers, including solid tumors, combining switchable universal CAR-T technology with a CRISPR/Cas9-based allogeneic platform.

BiotechLongevityMedical Devices

Andrew Schiermeier(Chief Executive Officer)in

Co-investorsNovo Holdings Blackstone Life Sciences Eight Roads Ventures NYBC Ventures

AviadoBioaviadobio.com in 𝕏

AviadoBio is a gene therapy company developing adeno-associated viral (AAV) treatments for neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).

BiotechDeep TechDigital HealthHealthtech

Chris Shaw(Co-Founder & Chief Scientific and Clinical Advisor)inDo Young Lee(Co-Founder)Youn Bok Lee(Co-Founder)in Lisa Deschamps(Chief Executive Officer)in Graeme Fielder(Chief Operating Officer)inAlex Bloom(Chief Development Officer)in

Co-investorsAdvent Life Sciences Dementia Discovery LifeArc Ventures Monograph Capital Partners New Enterprise Associates (NEA)SV Health Investors

Avidity Biosciencesaviditybiosciences.com inSeries B · Jan 2017 · $16M

Avidity Biosciences develops Antibody Oligonucleotide Conjugates (AOCs) that combine monoclonal antibody specificity with oligonucleotide precision for targeted delivery of RNA therapeutics to treat rare genetic muscle diseases.

BiotechDeep TechHealthtechMedical DevicesLa Jolla, US

Troy Wilson PhD., JD(Executive Officer, Director)P. Kent Hawryluk(Executive Officer)inMark E. Davis(Director)Troy Wilson(Executive Officer, Director)in

BoardTodd Brady(Director)Michael Martin PhD.(Director)

Co-investorsAvoro Capital Advisors Brace Pharma Frazier Life Sciences Moore Venture Partners

Avivomedavivomed.com

Avivomed is a medical device company developing minimally invasive neuromodulation therapies for patients with obstructive sleep apnea.

BiotechDeep TechHealthtechMedical DevicesRoseville, US

Lynn Elliott(Co-Founder)Mudit Jain(Co-Founder)Paul Mazanec(Chief Executive Officer)inStephen Masson(Executive Officer, Director)

BoardTheresa C. Pappas(Director)Ketan Patel(Director)in

Co-investorsHatteras Venture Partners Treo Ventures, Llc

Axle Healthaxlehealth.com in 𝕏Series A · May 2025 · $10M

Axle Health provides a logistics and scheduling platform for home health care providers that optimizes clinician routing, staffing decisions, and patient coordination through real-time data and predictive forecasting.

AI & Machine LearningDigital HealthHealthtechLogistics & Supply ChainSaaSLos Angeles, US

Adam Stansell(Founder)inConnor Hailey(Founder)Ian Arko(Head of Engineering)Andii Lee(Head of People and Talent)Alexa Sarachan(Operations Coordinator)

Co-investorsLightbank Pear VC Pioneer Rebel Fund Soma Capital TRAC (Third Round Analytics Capital)+1 more

Axoniaxoni.com in 𝕏Series B · Dec 2016 · $18MAcquired

Axoni provides a distributed ledger platform for post-trade processing and settlement in financial markets, serving institutional clients in capital markets operations.

Crypto & Web3Data & InfrastructureEnterprise SoftwareFintechSaaSNew York City, US

Greg Schvey(CEO)Jeffrey Schvey(CTO)inGreg (CEO)(Chief Executive Officer)Jeff (CTO)(Chief Technology Officer)Lindsay Drabczyk(People Operations Manager)Kristina Karcic(People)

Co-investorsAndreessen Horowitz Coatue Management Communitas Capital Partners DCVC (Data Collective)Digital Currency Group Y Combinator +16 more

Beadsbeads-hospice.jp

Beads Hospice operates a residential facility in Japan that provides palliative and end-of-life care for patients with terminal cancer, neurodegenerative diseases, and other specified conditions.

Digital HealthHealthtechLongevityWellness & Fitness福岡市, JP

Co-investorsEight Roads Ventures

Benchlingbenchling.com in 𝕏Series B · Apr 2016 · $15M

Benchling provides a cloud-based R&D platform for life sciences, combining a collaborative electronic lab notebook, structured scientific data modeling, automated workflows, and AI tools.

AI & Machine LearningBiotechEnterprise SoftwareSaaSSan Francisco, US

Sajith Wickramasekara(CEO)inAshutosh Singhal(Founder)Ashu Singhal(Founder)inCheng Kang(Founder)Cornelius Chen(Founder)Cory Li in

Co-investorsAlkeon Innovation Andreessen Horowitz Artisanal Ventures Balaji Srinivasan Draper Associates Ensemble Labs +31 more

Benchscibenchsci.com in 𝕏Series B · Feb 2020 · $22M

BenchSci builds AI infrastructure for preclinical drug discovery, using machine learning that reads scientific literature to extract experimental evidence and map disease biology for biopharma R&D teams.

AI & Machine LearningBiotechData & InfrastructureDigital HealthHealthtechToronto, US

David Qixiang Chen, PhD(Founder)inElvis Wianda(Founder)in Liran Belenzon(Founder)in Tom Leung(Founder)inDavid Q. Chen(Founder)

Co-investorsInovia Capital Generation Investment Management Gradient Ventures TCV 500 Global Afore Capital +8 more

Better Life Partnersbetterlifepartners.com in 𝕏Series B · Aug 2023 · $27M

Better Life Partners provides same-day medication-assisted treatment for opioid and alcohol addiction, combining counseling, community support, and medication for people in recovery.

Digital HealthHealthtechMental HealthHanover, US

Adam Groff(Executive Officer, Director)inJuliana Ekong(Executive Officer, Director)Myechia Minter-Jordan(Director)Steven Kelly(Executive Officer)

Board Yair Schindel(Director)in Jon Lim(Director)in

Co-investorsAlumni Ventures aMoon .406 Ventures Maverick Ventures

Bioregenbioregenmed.com

BioRegenMed is a high-tech company developing biomedical materials for trauma repair and tissue regeneration.

BiotechMedical DevicesNew MaterialsChangzhou, CN

Co-investorsEight Roads Ventures

Bison Trailsbisontrails.co 𝕏acquired by Coinbase

Crypto & Web3Developer ToolsFintechSaaSSan Francisco, US

Aaron Henshaw(Founder)Joseph Lallouz(Executive Officer, Director)Joe Lallouz(Founder)

Board Nicholas Chirls(Director)in

Co-investorsA.Capital Ventures Blockchain Coinvestors Charge VC Collab+Currency ConsenSys Mesh Galaxy Ventures +8 more

Black Ducksynopsys.com in 𝕏Aug 2014

Synopsys provides design automation tools and intellectual property for semiconductor and electronics companies to develop smart, connected devices.

Developer ToolsEnterprise SoftwareSemiconductorsBurlington, US

Doug Levin(Founder)Aart de Geus(Founder)inStephen N. Gregorio(Executive Officer)Philip B. Granof(Executive Officer)William NMN Ledingham(Executive Officer)Norman L. Shipley(Executive Officer, Director)

Co-investorsAsset Management Company Brightspark Ventures Crosslink Capital DataTribe Differential Ventures Francisco Partners +11 more

Blackducksoftwareblackducksoftware.com in

Black Duck provides an application security testing platform that unifies SAST, SCA, DAST, IAST, and AI-powered analysis to detect and remediate software vulnerabilities, license compliance risks, and code quality issues across the development lifecycle.

CybersecurityDeveloper ToolsSaaS

Co-investorsEscalate Capital Partners Sapphire Ventures Volition Capital

Blue Rabbitbluerabbit.vet in

Blue Rabbit is an online veterinary pharmacy that integrates with practice management software to automate prescription fulfillment and patient data management.

E-commerceHealthtechMedical DevicesSaaS

Bluebird Kids Healthbluebirdkids.com inSeries A · Mar 2025 · $32M

Bluebird Kids Health provides pediatric care services with a family-centered approach.

Digital HealthHealthtech

Chris Johnson(Founder, Chief Executive Officer)in Rachel Wilson(Co-Founder, Chief Operating Officer)inDr. Michael Glazier, MD(Co-Founder, Chief Medical Officer)Elizabeth Larsen(Co-Founder, Chief of Staff)in

Co-investors.406 Ventures AIF JUXTAPOSE VENTURES

Blueprint Medicinesblueprintmedicines.com in 𝕏

Blueprint Medicines is a biopharmaceutical company that discovers and develops targeted medicines for patients with diseases such as gastrointestinal stromal tumor and other conditions driven by genetic changes.

BiotechHealthtechCambridge, US

Nick Lydon(Director)Christoph S. Lengauer(Executive Officer)inChristine Bellon(Executive Officer)inKyle Kuvalanka(Executive Officer)in

BoardAlexis Borisy(Executive Officer, Director)Daniel Lynch(Director)

Co-investorsForesite Capital Nextech Invest RA Capital Ridgeback Capital Wellington Management Third Rock Ventures

Buoybuoy.moneyAug 2017 · $6.7M

Buoy provides an embedded finance API for working capital and liquidity management, letting treasury managers request on-demand top-ups when prefunding accounts run low.

FintechSaaS

Dan Kleinbaum(CEO)

Co-investorsTimon Capital FundRx Humana Optum Ventures Trustbridge Partners WR Hambrecht

Burroburro.ai in 𝕏Jan 2024 · $24M

Burro builds autonomous robots for agricultural and outdoor operations that mow, tow, carry, and spray to automate manual labor tasks.

AgTechAI & Machine LearningRobotics

Terry Scott(Founder)inCharlie Andersen(Founder)Vibhor Sood(Founder)

Co-investorsAsimov Ventures Catalyst Investors CIBUS ENTERPRISE FUND II LP Everywhere Ventures Ff Venture Capital NextFab Ventures +6 more

Cadence Neurosciencecadenceneuro.com inMay 2023 · $26M

Cadence develops a neuromodulation system intended to be a more effective, less invasive treatment for people living with drug-refractory epilepsy.

BiotechDigital HealthHealthtechMedical DevicesSammamish, US

Kent Leyde(Executive Officer, Director, Promoter)inWarren Douglas Sheffield(Executive Officer, Director, Promoter)

Co-investorsJAZZ Venture Partners Lumira Ventures Angelini Ventures Iaso Ventures Mayo Clinic Ventures

Canary Technologiescanarytechnologies.com in 𝕏Series A · Feb 2022 · $15M

Canary Technologies provides digital management software for hotels, replacing traditional paper-based administrative and operational workflows used across the hospitality industry.

Enterprise SoftwareSaaSNew York City, US

Harman Narula(Founder)inSJ Sawhney(Principal)inBryan Michalis(Strategic Initiatives)Stuart Moncada(Vice President Product)Blake VanLandingham(Head of engineering)

Co-investors7BC Venture Capital Brighton Park Capital Commerce Ventures DERIVE VENTURES G Ventures Insight Partners +13 more

Candidcandidco.com in

Candid develops clear aligner technology and offers remote monitoring services for dental professionals to deliver orthodontic treatment.

ConsumerDigital HealthHealthtechMedical Devices

Nick Greenfield(Founder)in

Co-investorsA-Rod Corp Averin Capital Bessemer Venture Partners Beyond Capital Fantail Ventures Hanaco Venture Capital +9 more

Canoe Intelligencecanoeintelligence.com in

Canoe Intelligence provides AI-driven software and data infrastructure for alternative investment management, processing capital call notices, distribution notices, and capital account statements from institutional fund managers to deliver real-time visibility into capital flows across trillions in assets under administration.

AI & Machine LearningData & InfrastructureEnterprise SoftwareFintechSaaS

Jason Eiswerth(CEO)in Noel Calhoun(CTO)in

Partner David Jegen· led

Co-investorsInner Loop Capital Goldman Sachs

Caplin Point Laboratoriescaplinpoint.net in

Caplin Point Laboratories is a pharmaceutical manufacturer that produces ointments, creams, external applications, and other formulations.

Advanced ManufacturingBiotechHealthtechChennai, IN

C.C. Paarthipan(Chairman)Sridhar Ganesan(Managing Director)in

Carestackcarestack.com in 𝕏Apr 2021 · $25M

CareStack is a cloud-based, all-in-one dental practice management software covering scheduling, patient experience, clinical workflows, revenue cycle management, analytics, and compliance.

Digital HealthHealthtechSaaS

Abhi Krishna(Founder)Abhilash Krishna(Founder)Abilash Krishna(Founder)Kevin Cook(Founder)Mark Huzyak(Founder)Varun Nelson(Founder)

Co-investorsAccel Callapina Capital Eight Roads Ventures Steadview Capital

Carrot Fertilityget-carrot.com in 𝕏Series C · Jun 2023

Carrot is a global fertility and family-building platform that provides access to fertility care, maternity support, and family-building guidance for individuals and families.

FemTechHealthtechHR TechSan Francisco, US

Asima Ahmad(CMO)in Tammy Sun(Founder)inDavid Utley(Executive Officer, Director)Dr. Asima Ahmad(Founder)Arun VenkatesanMaxwell Radomsky

Co-investors515 Ventures All Turtles Aurum Backstage Capital Core Venture Capital CRV (Charles River Ventures)+18 more

Cartesian Kineticscartesiankinetics.com in

Cartesian Kinetics develops "Physical AI" for fulfillment and warehouse operations, combining automation software and rack-native robotics that work within a facility's existing racks, systems and workflows rather than requiring a rebuild.

AI & Machine LearningHardwareLogistics & Supply ChainRoboticsSaaSSan Jose, US

Co-investorsCelesta Capital Kae Capital

Casacasa.io in 𝕏

Casa provides self-custody solutions for bitcoin and stablecoins, offering multi-signature security infrastructure for both individual and institutional users.

Crypto & Web3Fintech

Nick Neuman(Founder & CEO)in

Co-investors515 Ventures Acrew Capital Blockchain Coinvestors Champion Hill Ventures Coinbase Ventures Fabric Ventures +11 more

Castlecastle.io in 𝕏Seed · Jan 2019

Castle builds trust infrastructure for the modern internet, helping organizations detect and prevent fraud and account takeover attacks.

CybersecurityDeveloper ToolsEnterprise SoftwareSaaSSan Francisco, US

Johan Brissmyr(CEO)in Sebastian Wallin(CTO)in Max Nussenbaum(Founder)in Scott Lowe(Founder)in Tim Dingman(Founder)in

Board Shardul Shah in

Co-investorsFirst Round Capital Index Ventures Y Combinator FundersClub Walking Ventures Boost VC +8 more

Castlegetcastle.com inFeb 2019 · $9.2M

Castle builds payments infrastructure for homeowners, starting with a bill-pay app that helps them automate, consolidate, and reduce their household spending.

FintechPropTech

Co-investorsSuffolk Technologies Index Ventures Y Combinator

Castlecastle.finance 𝕏Feb 2019 · $9.2M

Castle offers a treasury yield management product that lets DAOs and other liquidity providers put their treasury assets to work in DeFi according to their risk profile.

Crypto & Web3Fintech

Co-investorsMDSV CAPITAL Index Ventures Y Combinator

Castorcastoredc.com inSeries B · Jul 2021 · $45MDefunct

Castor developed decision-support software that analyzed CAD files to help manufacturers decide between additive manufacturing and traditional production, offering cost and lead-time comparisons.

AI & Machine LearningCloud ComputingData & InfrastructureDigital HealthHealthtechMedical DevicesSaaSTel Aviv, IL

Derk Arts(Founder)in

Co-investorsAsahi Kasei Corporate Venture Capital Inkef Techstars Chartered Group Two Sigma Ventures

Centivocentivo.com inSeries A · Jul 2018 · $34M

Centivo is a primary-care-centered health plan administrator for self-funded employers, sold through benefits brokers and consultants.

Digital HealthHealthtechInsurTech

Alan Cohen(Founder)inAshok Subramanian(Founder & CEO)inStuart Roth(Founder)in

Co-investorsAlumni Ventures B Capital Group B4 Capital Bain Capital Ventures Basecamp Fund Cox Enterprises +7 more

Chaos Labschaoslabs.xyz in 𝕏Aug 2024

Chaos Labs builds AI-driven intelligence and risk-management infrastructure that converts fragmented data into institutional-grade insights, offering risk simulations, parameter tuning, and oracle technology for crypto protocols and financial institutions.

AI & Machine LearningCrypto & Web3Data & Infrastructure

Omer Goldberg(Founder)in

Co-investorsBalaji Srinivasan BlueYard Capital Coinbase Ventures Galaxy Ventures Haun Ventures Lightspeed Venture Partners +14 more

Charmwithcharm.appSep 2025

Charm is a payments and savings app that enables users to send money across different platforms (Venmo, Cash App, Zelle) through a unified interface, with funds earning interest when held in the app.

ConsumerCrypto & Web3FintechSocialNew York City, US

Gray Newfield(Founder)in Noah Newfield(Founder)inChristian Rocha(Founder)Toby Padilla(Founder)

Co-investorsPioneer Y Combinator 468 Capital Cavalry Ventures Firestreak Ventures Fuel Capital +7 more

Charmcharm.land 𝕏Sep 2025

Charm builds open-source tools and libraries for creating user interfaces and applications in the terminal, including command-line interface frameworks, markdown readers, and components for developers.

Developer Tools

Co-investorsBetaworks Cavalry Ventures Gradient Ventures Lowercarbon Capital Motive Force NAP +5 more

Charmcharm.fi 𝕏Sep 2025

Charm.fi is a decentralized finance platform offering automated liquidity management vaults on Ethereum, letting users browse or create vaults for any token and build LP strategies to manage liquidity and earn yields.

Crypto & Web3Fintech

Co-investorsCoinbase Ventures Cavalry Ventures Fuel Capital Gradient Ventures Khosla Ventures New Enterprise Associates (NEA)+2 more

Cipla Healthciplahealth.in in

Cipla Health is a consumer healthcare subsidiary that sells branded over-the-counter health products including throat lozenges, cough remedies, probiotics, oral care, and wellness supplements.

ConsumerHealthtechWellness & Fitness

Cloudantcloudant.comacquired by IBM

IBM Cloudant is a managed NoSQL database service based on Apache CouchDB, designed for building hyperscale, globally distributed applications with features including encryption, multi-region availability, full-text search, and geospatial indexing.

Cloud ComputingData & InfrastructureEnterprise SoftwareBoston, US

Michael Miller(Chief Scientist)inAlan Hoffman(Director of Product)inAdam Kocoloski(CTO)inMatt HumphreyStefano J. Attardi(Designer \u0026 Front-End Developer)

Partner David Jegen· led

Co-investorsAvalon Ventures Management, Llc Carbide Ventures In-Q-Tel Toba Capital Y Combinator Devonshire Investors +2 more

Clstclst.com

CLST is a Zurich-based platform for institutional crypto and stablecoin lending with automated negotiation and risk assessment.

Michael Guzik(Founder)in

Co-investorsCoinbase Ventures Digital Currency Group SICTIC TX Ventures

Codeshipcodeship.com in 𝕏acquired by CloudBees

Cloud ComputingDeveloper ToolsEnterprise SoftwareSaaSBrookline Village, US

Moritz Plassnig(CEO)inSacha Labourey(Co-founder)François Déchery(Co-founder)Manuel Weiss(Executive Officer)inFlorian Motlik(Executive Officer)in

BoardJohn SImon(Director)

Co-investorsAscent Venture Partners Camber Partners Golub Growth Matrix NewView Capital Rembrandt Venture Partners +4 more

Coin Metricscoinmetrics.io in 𝕏

Coin Metrics provides market and on-chain data, reference rates, and indexes for crypto and digital assets, delivered to institutional investment teams via APIs.

Crypto & Web3Data & InfrastructureFintechBoston, US

Tim Rice(Founder)inAleksei Nokhrin(Founder)Alexander Bich(Founder)Jacob Franek(Founder)

BoardMathew S. McDermott(Director)Sean Judge(Director)in

Co-investorsAcrew Capital Blockchain Coinvestors Coinbase Ventures Collab+Currency Communitas Capital Partners Digital Currency Group +10 more

Coincovercoincover.com in 𝕏

Coincover provides encryption-based protection and recovery for crypto private keys, sharding key material across independent parties so no single provider holds a complete key.

Crypto & Web3CybersecurityFintechCardiff, GB

David J.(Founder)inDavid Janczewski Adam Smith in

Co-investors13books Capital Foundation Capital Insurtech Gateway Fund Valor Equity Partners Development Bank of Wales Element Ventures +2 more

ConnexPayconnexpay.com inOct 2022

ConnexPay provides a payment platform that lets businesses accept customer payments and fund immediate supplier payments via virtual cards from the same transaction, closing the cash flow gap.

FintechSaaSTravel & HospitalityBonita Springs, US

Robert Kaufman(Chief Executive Officer and member of the Board of Managers)in

Board Mark Buffington(Member of the Board of Managers)inJacob Eisen(Member of the Board of Managers)Pamela Joseph(Member of the Board of Managers)Barbara Polsky(Member of the Board of Managers)

Co-investorsBIP Ventures FTV Capital Tamiami Angel BIP Capital

Core Diagnosticscorediagnostics.in in 𝕏Dec 2016

Core Diagnostics offers diagnostic laboratory testing with sample collection services, including routine tests and diagnostic monitoring tests scheduled at defined intervals.

BiotechDigital HealthHealthtechMedical Devices

Co-investorsArtiman Ventures Eight Roads Ventures

Countablecountable.com

Actionable is a self-service advocacy platform that lets organizations launch, manage, and measure campaigns such as petitions, pledges, lawmaker messages, and supporter mobilization without developers or consultants.

GovTechImpact & Social GoodSaaSOakland, US

Bart Myers(Executive Officer, Director)

Board Joydeep Bhattacharyya(Director)in

Co-investorsCanaan Partners Fernbrook Capital Management Silicon Valley Source Ventures

Countable Labscountablelabs.com in 𝕏Series A · May 2026 · $26M

Countable Labs (formerly Enumerix) develops Countable PCR, a DNA quantification technology that provides absolute target counts at single-molecule resolution as an alternative to qPCR, digital PCR, and NGS.

BiotechDeep TechHealthtechMedical DevicesPalo Alto, US

Stephen Fodor(Co-Founder & Board Director)Ari Chaney(Co-Founder & Board Director)in Christina Fan(Co-founder + CTO)inGiovanna Prout(Chief Executive Officer)in

Co-investorsARCH Venture Partners Primer Ventures

Curegenix Corporationcuregenix.com

Curegenix is a clinical-stage biopharmaceutical company founded in 2009 that develops small-molecule drugs targeting the WNT signaling pathway, including lead candidate CGX1321, for cancer and tissue repair, with operations in California and Guangzhou, China.

Curie Biocurie.bio in

Curie.Bio is a biotech venture firm pairing seed capital with in-house drug discovery support for therapeutics founders.

Zach Weinberg(Founder)inAlexis Borisy(Founder)Christoph Lengauer(Founder)

Co-investorsAlleyCorp ARCH Venture Partners BoxGroup DNA Capital GV (Google Ventures)Lightstone Ventures +5 more

Curvancecurvance.com 𝕏

Curvance is a decentralized finance protocol that combines depositing, borrowing, leveraging, swapping, and yield earning into a single dashboard.

Crypto & Web3Fintech

Co-investorsV3V Ventures Yunt Capital Curve Flowdesk FRAX Finance GSR +4 more

Cyclopscyclops.io in 𝕏Jul 2026

Cyclops is a unified crypto and stablecoin platform built specifically for payments companies, combining licensing, custody, compliance, and 24/7 settlement into a single integration.

Crypto & Web3FintechSaaSMiami, US

Alex Wilson(Founder)in

Co-investorsNava Ventures Castle Island Ventures Circle & Co.Coinbase Ventures

Cyclopscyclopsmedtech.com in 𝕏Jul 2026

Cyclops Medtech develops a portfolio of vestibular diagnostic and therapy products—including videonystagmography (VNG/VOG), video head impulse testing (vHIT), dynamic visual acuity, stabilometry platforms, VR-based vestibular rehabilitation, and a smart balance board—to diagnose and treat dizziness and balance disorders.

Digital HealthHealthtechMedical Devices

Co-investorsCapria Ventures Castle Island Ventures Circle & Co.Coinbase Ventures Nava Ventures

Dara5dara5.com inJun 2025

A community and investment platform that connects Gen Z and millennial entrepreneurs with venture capital and private equity opportunities in Europe and the US, offering networking, academy programs, and professional development.

Fintech

Eyal Raphael Samovich(Founder)in Oliver Hardcastle(Founder)in

Co-investorsAllied Venture Partners AMK Investment Office Acronym Venture Capital Alumni Ventures Spark Capital

Dataplordataplor.com in 𝕏Series B · Jun 2025 · $21M

Dataplor provides global point-of-interest, mobility, and brand location data with AI-powered analytics for investors to assess market share, growth trends, and foot traffic.

AI & Machine LearningData & InfrastructureEnterprise SoftwareFintechRetail TechSaaS

Co-investorsAlumni Ventures APA Venture Partners Blue Ivy Ventures Blue Startups Circadian Ventures Ff Venture Capital +21 more

Deal Enginedealengine.tech inNov 2022 · $5.3M

Deal Engine provides a white-labeled, AI-powered data platform that helps private equity firms and investment banks identify and progress deals in real-time by codifying coverage strategies and delivering actionable market intelligence across integrated systems.

AI & Machine LearningEnterprise SoftwareFintechSaaSLondon, GB

Phil Westcott(CEO)in

Co-investorsFINTOP Capital

Deal Enginedeal-engine.comNov 2022 · $5.3M

Deal Engine provides automated refund and change management solutions for the travel industry.

AI & Machine LearningSaaSTravel & HospitalityMiami, US

Co-investorsDorm Room Thayer Ventures

Debutdebutbiotech.com in

Debut applies AI and biotechnology to discover and formulate cosmetic ingredients and beauty products, decoding skin and hair at the genomic level to create novel actives.

Advanced ManufacturingAI & Machine LearningBiotechConsumerSan Diego, US

Joshua Britton(Founder)inBrady Beauchamp(Founder)Greg Weiss(Founder)

Board Cain A. McClary(Director)in

Co-investorsGS Futures Material Impact Breakout Ventures KdT Ventures Sandbox Industries ACVC Partners +12 more

Devoted Healthdevoted.comSeries A · Oct 2017 · $62M

Devoted Health offers Medicare Advantage plans and integrated healthcare services for older Americans, including virtual and in-home care, member support guides, and coordination with local providers across 29 states.

HealthtechInsurTechUnited States, US

Todd Park(Founder)inEd Park(Founder)in

Board Bryan Roberts(Director)in Robert Kocher(Director)in William Frist(Director)inKathleen Sebelius(Director)

Co-investorsAndreessen Horowitz Bronze Investments Capital Factory Cox Enterprises Dns Capital Dreamers VC +29 more

Dimension Therapeutics inSeries B · Apr 2015 · $65Macquired by Ultragenyx Pharmaceutical · Oct 2017 · $152.3M

Dimension Therapeutics was a Cambridge, Massachusetts biopharmaceutical company developing AAV-based gene therapies for rare liver-associated metabolic diseases like hemophilia, OTC deficiency, and glycogen storage disease.

Cambridge, US

Annalisa Jenkins(Executive Officer, Director)

BoardBenjamin Auspitz(Director)Donald J. Hayden(Director)Allan Fox(Director)

Co-investorsNew Leaf Venture Partners OrbiMed

Dinaridinari.com in 𝕏May 2025

Dinari provides tokenized stocks and ETFs (dShares) that combine traditional equity securities with blockchain-based digital assets, serving financial institutions like neobanks, fintechs, brokerages, and institutional traders across 85+ jurisdictions.

Crypto & Web3FintechPalo Alto, US

Gabriel Otte(Executive Officer, Director)in Altay Malazgirt inJake Timothyin

Co-investors500 Global Alliance DAO (ex DeFi Alliance)Factor Capital Hack VC Sancus Ventures Silvermine Capital +4 more

Dispatch iodispatch.io in

Dispatch is a data orchestration platform that connects wealth technology software by automating client data collection and synchronization across advisory firm tech stacks.

Data & InfrastructureEnterprise SoftwareFintechSaaS

Rob Nance(Co-founder, CEO)in Madalyn Armijo(Co-founder, COO)in Rafi Lurie(Co-founder, CPO)in

Co-investorsBrewer Lane Ventures Fika Flyover Capital MassMutual Ventures New York Life Ventures Perceptive Ventures Management Company, Llc +3 more

Docereedoceree.com in 𝕏Series A · Sep 2023 · $35M

Doceree offers a software platform for pharmaceutical brand teams, positioned as a single "system of work" that unifies market research, HCP targeting, media planning, measurement, CRM, and MLR workflows in place of fragmented tools.

AdTechDigital HealthMarketing TechSaaSShort Hills, US

Harshit Jain(Founder & Global CEO)in Kamya Elawadhi(Co-Founder & President)inPulkit Jain(VP - Finance & Investments)in Vijay Adapala(Chief Business Development Officer)inThomas Shea(Chief Revenue Officer, AI and Patient Affordability Solutions)inYesh Srinivasan(Chief AI Officer)

Co-investorsAlkemi Growth Capital Eight Roads Ventures

Dust Identitydustidentity.com inJul 2019

Dust Identity develops physical identity solutions using diamond-based technology to authenticate and trace high-value products and components across supply chains.

Circular EconomyDeep TechDefense TechEnterprise SoftwareHardwareIoTNew MaterialsRetail TechNeedham, US

Ophir Gaathon(Founder)inDirk Englund(Founder)

Board Ilya Fushman(Director)in

Co-investorsAlumni Ventures Angular Ventures Blockchain Coinvestors Grit Ventures Motier Ventures New Science Ventures +7 more

Eaglebrook Advisorseaglebrook.com in

Eaglebrook is a crypto investment platform for wealth managers, offering tax-optimized Bitcoin, Ethereum, and multi-asset separately managed accounts (SMAs) held in segregated accounts at qualified custodians.

Crypto & Web3FintechSaaS

Christopher King(Founder)in

Co-investorsBrewer Lane Ventures Hack VC Avon Ventures Castle Island Ventures Flyover Capital Franklin Templeton +3 more

Eigen Innovationseigen.io inAug 2026 · $20M

Eigen Innovations develops AI vision software and solutions for manufacturing enterprises to enable digital transformation and improve operational efficiency.

Advanced ManufacturingAI & Machine LearningEnterprise SoftwareHardwareFredericton

SCOTT EVERETT(Director)in Paul Scherer(Founder)inRICHARD JONES(Executive Officer, Director)in Erin Barrett(Chief Executive Officer)in

BoardBILL BARRETT(Director, Promoter)RICKY DUBAY(Director)

Co-investorsCeltic House Asia Partners East Valley Ventures First Angel Network Association (FAN)Momenta Ventures AGI HOUSE VENTURES Aramco Ventures +9 more

Elementuselementus.io in

New York, US

Max Galka(Executive Officer, Director)inNuria Gutiérrez Prunera(Founder)Chris Lipowicz inVladimir Jelisavcic(Director)

Board Anthony Pompliano(Director)in

Co-investorsMoonshots Capital ParaFi Capital Velvet Sea Ventures Avon Ventures Gemini Frontier Fund Lightspeed Venture Partners +2 more

Eleoseleos.co.uk in 𝕏Nov 2023 · $40M

Eleos offers life insurance and income protection to consumers in the UK, with an app-based process that explains cover in plain English, provides instant answers, and connects users to licensed experts by WhatsApp, email, or phone.

FintechInsurTech

Co-investorsaMoon Arkin Capital Fuel Ventures Heartfelt Capital InsurTech Eight Roads Ventures +4 more

Eleos Healtheleos.health inSeries A · Nov 2023 · $40M

Eleos develops AI-powered software that helps behavioral health clinicians deliver more effective care through data measurement and personalization.

AI & Machine LearningDigital HealthHealthtechMental HealthCambridge, US

Alon Joffe(Founder)inDror Zaide(Founder)inAlon Rabinovich(Founder)in Denny Morrison(Chief Clinical Officer)in Raz Karmi(Chief Information Security Officer)in Noam Cohen(VP of R&D)in

Co-investorsaMoon Arkin Capital Arkin Digital Health Greenfield Partners Lool Ventures Maccabee Ventures +3 more

Elucidataelucidata.io in 𝕏Series A · Sep 2022 · $16M

Elucidata is a company oriented around supporting scientific research, emphasizing making users' research more efficient and respecting the scientific method.

AI & Machine LearningBiotechData & InfrastructureCambridge, US

Abhishek Jha(Co-founder & CEO)Swetabh Pathak(Director)in

Co-investorsHyperplane Venture Capital Eight Roads Ventures IvyCap Ventures

Embarkembarkvet.com in 𝕏

Embark Veterinary develops dog DNA tests and science-backed supplements for dog health and genetics.

BiotechConsumerHealthtech

Amish Desai(Chief Executive Officer)in Tali Ronen(SVP, People)inGrace Carter(VP, Finance)in

Co-investorsDCVC (Data Collective)FJ Labs Founder Collective FundersClub Peak Partners Slow Ventures +4 more

Engrail Therapeuticsengrail.com inSeries B · Mar 2024 · $170M

Engrail Therapeutics is a clinical-stage pharmaceutical company developing precision-targeted therapeutics for neupropsychiatric and neurodevelopmental disorders.

BiotechDigital HealthMedical DevicesSan Diego, US

Stephen(Co-founder, EVP Research & Development and Chief Development Officer)Paul Cayer(Chief Financial Officer)inVikram(President and Chief Executive Officer)Kimberly(Chief Scientific Officer)Quentin(Chief Technical Officer)

Co-investorsForesite Capital Longwood Fund Norwest Venture Partners Pivotal Life Sciences RiverVest Venture Partners Ysios Capital +4 more

Enzene Biosciences Ltdenzene.com in 𝕏Jan 2023 · $50M

Enzene Biosciences is a biologics company focused on the development and manufacturing of biopharmaceuticals.

Advanced ManufacturingBiotechHealthtechMedical Devices

Co-investorsEight Roads Ventures

Equipequip.health in 𝕏Feb 2022 · $58M

Equip provides virtual care and treatment services for eating disorders through a digital platform.

Digital HealthHealthtechMental HealthCarlsbad, US

Kristina Saffran(Co-founder)in Erin Parks(Co-founder, clinical psychologist)inJay Wuellner(Executive Officer)in Nikia Bergan(Executive Officer, Director)in Janice Tam(Executive Officer)in

Board Jon Lim(Director)in

Co-investors.406 Ventures Coalition Operators General Catalyst Optum Ventures PLUS Capital Stripes +3 more

Eris Innovationserisfutures.com in

Eris Innovations is an intellectual property licensing company that developed and patented the Eris Methodology, a way to list exchange-traded futures replicating interest rate swaps, which it licensed to CME Group for Eris SOFR Swap futures and Eris Options.

Fintech

Michael Riddle(Chief Executive Officer)in

Co-investorsCTC Ventures Chicago Trading Company Virtu Financial

Ethena Labsethena.fi 𝕏Feb 2025

Ethena operates a crypto protocol offering USDe, a digital dollar, and sUSDe, a reward-accruing asset backed by collateralized assets with third-party attestations.

Crypto & Web3Fintech

Guy Young(Founder)in

Co-investorsAlphaLab Capital Ataraxia Capital BitDAO Breed Caladan CVP NoLimit +21 more

EurekaBioeurekabio.com in

EurekaBio develops technologies and solutions for the cell and gene therapy (CGT) industry, focused on treatments for diseases such as cancer, rare diseases, genetic disorders, and auto-immune conditions.

BiotechDeep TechHardwareHealthtechMedical DevicesShenzhen, CN

Co-investorsMing capital

Even Financialevenfinancial.com inSep 2019 · $18.8MAcquired

Even Financial, operating as Engine, runs a financial services marketplace and matching network that connects consumers with financial products through APIs and white-labeled experiences.

AI & Machine LearningFintechMarketplacesBrooklyn, US

Phill Rosen(Founder & CEO)Ian Rosen(Executive Officer, Director)Jarid Maged(Executive Officer, Director)

Board Brendan Dickinson(Director)in

Partner David Jegen· led

Co-investorsAAF Management Ltd.Conversion Capital GreatPoint Ventures MassMutual Ventures Valuestream Ventures Canaan Partners +6 more

Expressableexpressable.com inMay 2024 · $26M

Expressable provides speech therapy services using research-based techniques with a focus on family engagement and accessibility.

Digital HealthHealthtechSaaSAustin, US

Nicholas Barbara(Executive Officer, Director)inLeanne Sherred(President and Chief Clinical Officer)inBenjamin Pincus(Executive Officer)inSpencer Magloff(Executive Officer)inRyan Hinojosa(Executive Officer)

Co-investorsDigitalis Ventures Lerer Hippeau NextView Ventures HarbourVest Partners (Canada)

Eyebright Medicalebmedical.com

Eaglet Eye Medical (Aibo Medical) is a China-based manufacturer of ophthalmic medical devices covering eye surgery treatment, myopia control, and vision care.

Advanced ManufacturingHealthtechMedical DevicesBeijing, CN

Eywa Biotecheywa.bio inOct 2016 · $30M

Eywa is a team of scientists and innovators focused on advancing mental health through research and partnerships.

BiotechDeep TechDigital HealthHealthtechMental Health

Co-investorsDraper Associates Ganesha Lab GRIDX ah! Ventures

FalconXfalconx.io in 𝕏

FalconX is a digital assets prime brokerage providing institutional clients with 24/7 access to liquidity and capital solutions through proprietary technology designed for risk management in volatile markets.

Crypto & Web3FintechSan Mateo, US

Raghu Yarlagadda(Founder)in Austin Reid in Suzy Walther in Brian Crist in Vanessa Zhang inPrabhakar Reddy(Founder)

Co-investorsAccel Accomplice B Capital Group B4 Capital Blockchain Coinvestors Cleo Capital +21 more

Fazeshiftfazeshift.com in 𝕏Series A · May 2026

Fazeshift provides enterprise-grade AI agents that automate accounts receivable processes for organizations, handling transaction processing, cash application, payment communications, and customer experience tasks.

AI & Machine LearningEnterprise SoftwareFintechSan Francisco, US

Caitlin Leksana(CEO)in Timmy Galvin(CTO)in

Co-investors2048 Ventures Gradient Ventures Phoenix Fund Pioneer Ritual Capital Wayfinder Ventures +2 more

Figment Networksfigment.io in 𝕏

Figment is an independent provider of staking infrastructure, offering non-custodial staking, reward tracking, API integrations, and slashing protection to institutional clients such as asset managers, exchanges, wallets, foundations, and custodians.

Crypto & Web3Data & InfrastructureEnterprise SoftwareFintech

Lorien Gabel(Founder)inAndrew Cronk(Founder)Matt Harrop(Founder)Ryan Funduk(Founder)

Co-investors10SQ Capital (TenSquared)10T Fund 3cubed Ventures AppWorks Ventures Archetype B Capital Group +23 more

Firefly Healthfireflyhealth.com inSep 2019 · $10.2M

Firefly Health provides virtual primary care through dedicated care teams that include primary care physicians, nurse practitioners, health guides, nurses, and behavioral health specialists.

Digital HealthHealthtechInsurTechMental HealthWellesley, US

Jeff Greenberg(Founder)inJustin Dangel(Executive Officer, Director)Fay Rotenberg(Executive Officer, Director)inShirley Mills(Executive Officer)

BoardJonathan James Bush(Director)

Co-investorsAndreessen Horowitz East 11 Ventures Floating Point MaC Venture Capital Oak HC/FT Premji Invest +2 more

Flipside Cryptoflipsidecrypto.com

Edisyl builds a semantic layer that encodes organizational understanding of data meaning, metrics definitions, and institutional knowledge to enable enterprise AI tools to answer questions aligned with business logic.

AI & Machine LearningData & InfrastructureEnterprise Software

Jim Myers(Founder)in

Co-investorsBoston Seed Capital Coinbase Ventures Converge Galaxy Ventures M13 The Chernin Group (TCG Crypto)+15 more

Flourish Healthflourish.healthSeries A · Jul 2026 · $26M

Flourish Health provides in-home mental health care for young people with serious psychiatric needs, combining clinical expertise with technology to deliver evidence-based treatment through multidisciplinary care teams.

Digital HealthHealthtechMental HealthNorth Carolina, US

Natalia Birgisson(CEO and Co-Founder)John Haskell(Co-Founder and President)Josh Gachnang(Co-Founder and Chief Technology Officer)

Co-investors25Madison Acumen America AV8 Ventures B Capital Group City Light Gratitude Railroad+5 more

Funnelfunnel.io in 𝕏

Funnel is an AI-native marketing data platform that aggregates, models, and governs marketing data from 600+ sources into a single layer, then adds measurement and reporting on top.

AI & Machine LearningData & InfrastructureMarketing TechSaaSStockholm, SE

Fredrik Skantze(Founder)Mike O'Toole(Founder)Per Made(Founder)

Co-investorsBalderton Capital Industrifonden NavisionGroup Oxx RET Ventures Trinity Ventures +4 more

FutureAdvisorfutureadvisor.comacquired by BlackRock

FutureAdvisor provides digital wealth management services to middle- and upper-middle-income households, offering automated portfolio management and financial advice at lower costs than traditional advisory firms.

FintechSan Francisco, US

Bo Lu(CEO)in Chris Nicholson(Head of Communications \u0026 Recruiting)in Jon Xu(President)in

Partner David Jegen· led

Co-investorsBling Capital Canvas Ventures Great Oaks Venture Capital Kapor Capital Y Combinator Agrolimen Ventures +2 more

Galatea Biogalatea.bioAug 2024 · $8M

Genomics company building a multi-ancestry biobank and AI-driven analytics for clinical genetic testing and drug discovery.

HealthtechMiami Lakes, US

Carlos D. Bustamante(Executive Officer, Director)inArthur Polk(Executive Officer)Alexander Ioannidis(Director)

Board Wale Ayeni(Director)inMohit Kaushal(Director)Nicholas Katsanis(Director)

Co-investorsCEI Ventures Citta Capital Founder Collective Function Ventures Helios Digital Ventures LifeX Ventures +4 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Amphora Medical Basecamp Bio Embark Veterinary, Inc.Parrot Technologies Inc / DEAbelian TherapeuticsAccuri CytometersAerium TherapeuticsAirespaceAkriveia TherapeuticsAlphagen TherapeuticsAlphaGen TxB One OrthoBang Er MedicalBetter Life MedicalBikam PharmaceuticalsBioconnect SystemsBiopaletteBTP AutomationCanoeCardiokineCitrine MedicineCogent BiosciencesDigital Assets DataFarapulseFcb HealthFoldrxFoldRx Pharmaceuticals

Browse all 459 investments with full details →

▶259 more tracked companies

Geneception Genoa PharmaceuticalsGenomicsGenomics PlcGeotelGrove Gst Clinics GurosGyennoHealth TechnologyHealthtech + ServicesHercle Hercle HilabsHile BiopharmaHone Hone Group HosekiHq Medical TechnologyHua Medicine Hurdle iCertis, Inc.IgluIkano TherapeuticsImmuneel ImmutrinIndalo TherapeuticsInnoventInnovent BiologicsInsilico Medicine Intuition Invetx Iora Health Iriva Medical Ironwood Pharmaceuticals Ivenix Judi Jump Jump K36 TherapeuticsK36 TxKanastra KenshoKilnKintsuKnowyourselfKyruus LakeShore Biopharma Latchel Laurus Bio Laurus Labs LeadIQLemonLemon CashLenomedLiazon LighthouseLighthouseLigocyteLimitless LimitlessLimitless ExchangeLiterablyLogixboard LunaPBC Madaket Marit Health MarketMuse MathisonMddfMedbanksMediTrust HealthMedwellMeld Menlo Therapeutics Mersana Therapeutics Metcela Metsera Mindshift MineralTreeModis TherapeuticsMoengage Monark Mozper MyoLab Mythical Games Nanos Medical Napster Nava Therapeutics nChroma Bio Nebula Nebula Genomics Neo4j NeuroSmart Inc.Nextwavepharma nocd Nocion Therapeutics NotableNovamed PharmaceuticalsNuanceNuance Communications NuanNvelop TherapeuticsNYDIGOakley NetworksOdaseva OncoveryCare Oncusp TherapeuticsOnCusp TxOnesilqOpennode Optimus Ride Orchard TherapeuticsOrient Speech Therapy OstOrigynmed OTA Insight Oviva Owkin Owncloud IncOxioOziva Papaya Payments Paradigm Health Paradigm Health Parrot Parrot Software 🦜PathPatientPingPediatrixPediatrix TherapeuticsPeptone Percy PharmEasyPiePie Ping Identity Plasmagen Biosciences Plume NetworkProcured HealthPromentis Pharmaceuticals Prosper Protenus Proteostasis Therapeutics Proximie Puffer Finance Pulmocide Quantum Circuits Quarry Thera Quartet Health QuovoR1 TherapeuticsRareStone GroupRareStone Group (Previously Citrine Medicine)ReadMeReceipts Depositary CorporationRecurly Redpine Regenx BiosciencesREGENXBIORemunixRespivertRezera RhyGaze AG Rialtic RightHand Rigimmune RIPPL Care RisklensRiskreconRoarkRugen TherapeuticsSana Biotechnology Scroll Securonix Seis Semma TherapeuticsSemma TxSeyond Shift Bioscience Shinobi Therapeutics Inc.Shinobi TxSilexonSilicon DataSimon AISingular GenomicsSingular Genomics Systems SironaxSkyline TherapeuticsSnapsheet Solidus Labs Solv Protocol SonderMind Space and Time Spectrumai Spinwheel Spry Stride HealthStructure TherapeuticsSTS DigitalSurface OncologySymbiomixSymbiomix Therapeutics T Therapeutics TandemaiTct Medical IncTeam Sector CryptoTeam Sector Life SciencesTeam Sector TechnologyTeleo Tenpoint Therapeutics Tenvie Tetraphase Pharmaceuticals The Giving Block Tokensoft Toku Toku Toku TokuTopaz PharmaceuticalsTraceLink TradeblockTransaveTreeent Triply Trivitron Healthcare truthsystems Turnstone BiologicsTwin1U S HealthVest UltragenyxUltragenyx PharmaceuticalUnbox RoboticsUnbxdUnison UNISONUnlocking mRNA deliveryUnlocking private, uncensored AIValor HealthValrVendrVeridVerve Therapeutics VestwellVicept TherapeuticsVitalwareVyne Therapeutics Wanhu Healthcare Warmly Welbe Health well beam Wellframe WhatfixWintermuteWww Akrevia ComXaira Therapeutics Xoom CorporationYishengbioZeen Health Zenefits ジェイファーマ株式会社

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Exits · 82

25 IPOs · 57 acquisitions · showing 37

Caribou BiosciencesNASDAQ: CRBUNeumora TherapeuticsNASDAQ: NMRApeerTransferNASDAQ: FLYWShouTi Inc.NASDAQ: GPCRXilio TherapeuticsNASDAQ: XLOAclaris TherapeuticsNASDAQ: ACRSAdageneNASDAQ: ADAGAdaptimmuneOTC: ADAPYAvalyn Pharma IncNASDAQ: AVLNBeam TherapeuticsNASDAQ: BEAMBicara TherapeuticsNASDAQ: BCAXCoherus BiosciencesNASDAQ: CHRSCoinbaseNasdaq: COINCompass TherapeuticsNASDAQ: CMPXCytek BiosciencesNASDAQ: CTKBDenali TherapeuticsNASDAQ: DNLIFlywireNASDAQ: FLYWInsmedNASDAQ: INSMPony.aiNASDAQ: PONYPrecision BioSciencesNASDAQ: DTILPrime MedicineNASDAQ: PRMERallybio, LLCNASDAQ: RLYBToastNYSE: TOSTUnum TherapeuticsNASDAQ: COGTAmphora Medicalacq. by HologicAbelian Therapeuticsacq. by Neumora TherapeuticsAirespaceacq. by CiscoApellis Pharmaceuticalsacq. by BiogenBikam Pharmaceuticalsacq. by ShireBison Trailsacq. by CoinbaseCardiokineacq. by Cornerstone TherapeuticsCloudantacq. by IBMCodeshipacq. by CloudBeesDimension Therapeuticsacq. by Ultragenyx PharmaceuticalFarapulseacq. by Boston ScientificFoldrxacq. by PfizerFutureAdvisoracq. by BlackRock

Portfolio news

latest coverage across their companies

STS Digital Launches Smart Bitcoin, Expanding Its Structured Products Offering with Quantitative Investment Strategies | ABC Money

STS Digital · abcmoney.co.uk · Sep 17, 2026

Prime Medicine to Participate in Upcoming September 2026 Investor Conferences - BioSpace

Prime Medicine · biospace.com · Sep 3, 2026

Capital Rx Raises $400 Million and Rebrands as Judi Health to Expand Beyond Pharmacy | Managed Healthcare Executive

Judi · managedhealthcareexecutive.com · Sep 1, 2026

Tenpoint Therapeutics launches with $70 million in funding for cell therapy platform | Eye Care Network - Ophthalmology Times Europe

Tenpoint Therapeutics · ophthalmologytimes.com · Aug 30, 2026

Recurly and Justt target the rising cost of chargebacks

Recurly · fintech.global · Aug 21, 2026

524742: Upcoming Dividend And Board Decisions Will Shape A Measured Outlook

Caplin Point Laboratories · simplywall.st · Aug 18, 2026

Deribit receives Broker-Dealer Licence from Dubai's VARA

Coinbase · Coinbase Blog · Aug 13, 2026

Silicon Data Raises $30.5M in Series A Funding

Silicon Data · finsmes.com · Aug 12, 2026

IPO stake values · per SEC filings · 2

Value of this firm's stake in each portfolio company at its IPO price, from the prospectus principal-stockholder table.

Company	Owned	IPO price	At IPO	Stake value
peerTransfer	7.3%	$24.00	May 2021	$179M
Flywire	7.3%	$24.00	May 2021	$179M

Source: SEC S-1 / 424B prospectus filings. Stake value = shares beneficially owned × the initial public offering price, as disclosed — a market value at IPO, not a return multiple (the firm's original cost is not disclosed).

Frequently asked questions

How many investments has F-Prime Capital made?: F-Prime Capital has 459 tracked investments, 82 of which have exited, including 49 dated in the last 24 months.
What stage does F-Prime Capital invest at?: F-Prime Capital invests at the Pre-Seed, Seed, Series A, Series B, Series C stages.
What is F-Prime Capital's typical check size?: F-Prime Capital typically writes checks of $3M – $10M.
What sectors does F-Prime Capital focus on?: F-Prime Capital focuses on AI & Machine Learning, Biotech, Crypto & Web3, Deep Tech, Digital Health, Enterprise Software, Fintech, Healthtech, InsurTech, Medical Devices, Mental Health, SaaS, Sector Agnostic.
Where is F-Prime Capital located?: F-Prime Capital is headquartered in Cambridge, US.
Does F-Prime Capital lead rounds?: Yes, F-Prime Capital leads investment rounds.
Who does F-Prime Capital co-invest with?: F-Prime Capital most often shares deals with GV (Google Ventures), ARCH Venture Partners, Y Combinator, among 865 tracked co-investors.

Media · Podcasts & interviews

featuring the team

F-Prime Capital's David Jegen shares the rationale behind the F-Prime Fintech Index

New York Stock Exchange · David Jegen

Images

Co-investors · 169

Eight Roads Ventures

Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.

Both backed · 52

$5M – $30M

GV (Google Ventures)

GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.

$250K – $50M

ARCH Venture Partners

ARCH Venture Partners is a venture capital firm that invests in and helps build transformational companies, with a strong focus on the life sciences and biotechnology sector.

$50K – $250M

Alumni Ventures

Alumni Ventures (AV) is a venture capital firm that co-invests alongside lead VCs in startups, backing founders with capital and access to a large investor and operator community.

Both backed · 19

Compass Therapeutics AvantStay Better Life Partners Centivo Dara5 Dataplor Dust Identity Judi LeadIQ Lemon Cash Mythical Games Napster Optimus Ride Parrot Software 🦜SonderMind Space and Time Spry Welbe Health Zus Health

$100K – $10M

Andreessen Horowitz

Andreessen Horowitz (a16z) is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz, known for pioneering the platform model with a large team of operators supporting founders across stages.

Both backed · 17

Coinbase Toast Axoni Benchling Curie Bio Devoted Health Dispatch io Firefly Health Intuition Mythical Games Nava Therapeutics PatientPing Prosper Tradeblock truthsystems Zenefits Zus Health

$500K – $50M

Foresite Capital

Foresite Capital is a healthcare-focused investment firm backing companies at the intersection of technology and biotechnology to personalize healthcare and accelerate medical innovation.

Both backed · 17

Aclaris Therapeutics Adaptimmune Beam Therapeutics Bicara Therapeutics Compass Therapeutics Denali Therapeutics Insmed Blueprint Medicines Engrail Therapeutics Generation Bio Genomics Plc Orchard Therapeutics Verve Therapeutics Xaira Therapeutics ZenefitsGenomicsStructure Therapeutics

New Enterprise Associates (NEA)

New Enterprise Associates (NEA) is a venture capital firm that invests in and provides long-term support to founders building new companies.

Both backed · 16

Adaptimmune Affinia Therapeutics Amber Therapeutics AviadoBio Black Duck Charm CHARM Therapeutics Comanche Biopharma Gst Clinics Mersana Therapeutics Proteostasis Therapeutics Stride Health Tempest Therapeutics Xaira Therapeutics Xoom CorporationSurface Oncology

$200K – $40M

General Catalyst

General Catalyst is a venture capital firm operating as a partnership focused on company building and accelerating the growth of the businesses it backs.

Both backed · 15

Almanac Health Benchling Black Duck Chaos Labs Devoted Health Equip Intuition Judi Kensho Paradigm Health RIPPL Care SonderMind Unbox Robotics UNISON Zenefits

$30M

OrbiMed

OrbiMed is a healthcare-focused investment firm providing tailored financing solutions and global resources to build world-class healthcare companies across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.

Both backed · 14

Compass Therapeutics Insmed Adela Carrot Fertility Charm CHARM Therapeutics Dimension Therapeutics Insilico Medicine Oncusp Therapeutics Promentis Pharmaceuticals Symbiomix Therapeutics Tandemai Turnstone Biologics Viewray

$1M – $75M

Bessemer Venture Partners

Bessemer Venture Partners is a global venture capital firm that partners with entrepreneurs across enterprise, consumer, and healthcare sectors from early stages through growth.

Both backed · 13

Insmed Toast Artemis Health Candid Chaos Labs Eigen Innovations Liazon NYDIG Papaya Payments Peptone PharmEasy ReadMeTwin1

$50K – $100M

B Capital Group

B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.

Both backed · 11

Avalyn Pharma Inc ARTBIO Centivo FalconX Figment Networks iCertis, Inc.Insilico Medicine Judi MoengageFlourish HealthMediTrust Health

$10M – $50M

Tiger Global Management

Tiger Global Management operates public equity strategies (long/short, long-focused and crossover) and a private equity business investing in early- through late-stage growth companies across new and existing industries.

Both backed · 11

Coinbase Toast Alkeon Capital Ashby Benchling Carrot Fertility Devoted Health Equip FalconX Snapdocs Vendr

$1M – $100M

▶157 more co-investors

Sequoia Capital .406 Ventures Sofinnova Ventures Khosla Ventures Menlo Ventures SoftBank Vision Fund Venrock Atlas Venture Accel Digital Currency Group RA Capital Insight Partners Bain Capital Ventures Spark Capital Sanofi Ventures Volition Capital Canaan Partners Oak HC/FT Polaris Partners Vivo Capital Casdin Capital Gradient Ventures Lux Capital Citi Ventures 5AM Ventures Digitalis Ventures Omega Funds RiverVest Venture Partners Founders Fund Greylock Partners Index Ventures Founder Collective FundersClub QED Investors American Express Ventures (Amex)Sofinnova Partners Advent Life Sciences Lightstone Ventures Kleiner Perkins Foundation Capital Great Oaks Venture Capital NextView Ventures Freestyle Capital Lerer Hippeau Social Leverage Winklevoss Capital TCV Fika 9Yards Capital EQT Life Sciences MassMutual Ventures JAZZ Venture Partners Maven Ventures Cambridge Innovation Capital Pivotal Life Sciences Brewer Lane Ventures Nextech Invest In-Q-Tel Optum Ventures aMoon Craft Ventures Benchmark First Round Capital CRV (Charles River Ventures)Plug and Play Ventures RRE Ventures Forerunner Ventures Headline Inovia Capital Pear VC US Venture Partners Threshold Ventures Dell Technologies Capital Flourish Ventures Ff Venture Capital Dawn Capital Kickstart Xfund Forum Ventures Jump Capital Versant Ventures Forbion Third Rock Ventures Abingworth Flagship Pioneering Arboretum Ventures Baird Capital Flyover Capital Anterra Capital AIF Red Tree Venture Redpoint Ventures Eniac Ventures UpHonest Capital SignalFire Scale Venture Partners Canvas Ventures Maveron Creandum Two Sigma Ventures Brainchild Holdings Heartcore Capital Nyca Partners Founders' Co-op Accelerator Ventures Jackson Square Ventures Golden Ventures BDC Venture Capital Highbury Holdings Pitango Arrive SparkLabs Global Ventures 7wire Ventures Zelkova Ventures GPO Fund Arthur Ventures Inkef Town Hall Ventures Illuminate Financial Questa Capital Brighton Park Capital CVS Health Ventures HealthQuest Capital DFJ 4BIO Capital JMI Equity Bluebird Ventures De Novo Ventures Helios Digital Ventures International Finance Corporation Alkemi Growth Capital Streamlined Ventures Physical Intelligence IA Ventures Upfront Ventures Wing General Partnership Better Tomorrow Ventures Saga Ventures Company Capital Work-Bench Mucker Capital Proximity Ventures Rubicon Venture Capital IrishAngels Stripe Uprising Bread And Butter Ventures, Llc Page One Ventures Venture Guides Management, L.P.Picture Capital Surface Ventures Fireblocks Vendep Capital Neon Adventures Nina Capital WillowWorks

Firms observed investing alongside F-Prime Capital, from public investor directories. Shared companies are the overlap with F-Prime Capital's recorded portfolio.

Similar investors

B Capital Group

B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.

$10M – $50M

Khosla Ventures

Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.

$100K – $20M

OMERS Ventures

OMERS Ventures is a venture capital firm that invests in founders globally, with investment teams based in New York, Palo Alto, and Toronto.

$5M – $25M

Everywhere Ventures

Everywhere Ventures is an early-stage venture firm that writes pre-seed checks and is backed by a community of founder and operator LPs.

$250K

Wormhole Capital

Wormhole Capital is the investment arm of Vivek Garipalli's family office, backing exceptional founders building transformative, category-defining companies, typically at the early and incubation stages.

Featured in lists

Investors & VC Firms in North America Seed Investors & VC Firms Investors & VC Firms in United States Series A Investors & VC Firms Seed Investors & VC Firms in North America Investors & VC Firms in Europe Pre-Seed Investors & VC Firms Seed Investors & VC Firms in United States Investors & VC Firms in Global AI & Machine Learning Investors & VC Firms Fintech Investors & VC Firms SaaS Investors & VC Firms

Website & social

fprimecapital.com

/f-prime-capital-partners @fprimecapital watch video

signal ↗crunchbase ↗Blog ↗

As published on the firm's website.

Contact

Cambridge1 Main St.
13th Floor
Cambridge, MA 02142
United States

London33 Foley Street
London W1W 7TL
United Kingdom

San Francisco140 New Montgomery Street
2nd Floor, Suite A
San Francisco, CA 94105
United States

Emailinfo@fprimecapital.com

Phone617-231-2400

Fax617-231-2425

FoxScore

Combines investment activity, responsiveness, founder feedback, closing rate and follow-through reported by founders on Fox. Sign up to see it.

Your history

F-Prime Capital isn't in your CRM yet.

+ Add to CRM

Track outreach, deck opens, and next steps across your whole raise.

✨ Smart outreach

✨ Best warm path

Funds

IMPRESA FUND IV LLCJun 2026 · 301 LPs$3.5BAUM

FMR CAPITAL HOLDINGS LLCJun 2026 · 298 LPs$3.1BAUM

IMPRESA FUND III LPJun 2026 · 138 LPs$2.7BAUM

42 NORTH RESOURCE PARTNERS II LPJun 2026 · 2 LPs$609.3MAUM

F-PRIME CAPITAL PARTNERS HEALTHCARE FUND V LPJun 2026 · 9 LPs$608.9MAUM

F-PRIME CAPITAL PARTNERS LIFE SCIENCES FUND VII LPJun 2026 · 9 LPs$606.3MAUM

F-PRIME CAPITAL PARTNERS LIFE SCIENCES FUND IX LPJun 2026 · 2 LPs$498.5MAUM

F-PRIME CAPITAL PARTNERS LIFE SCIENCES FUND VIII LPJun 2026 · 9 LPs$463.4MAUM

IMPRESA FUND VJun 2026 · 200 LPs$404.6MAUM

F-PRIME CAPITAL PARTNERS TECH FUND II LPJun 2026 · 9 LPs$358.2MAUM

DI CONSUMER FUND I LPJun 2026 · 2 LPs$352.8MAUM

F-PRIME CAPITAL PARTNERS LIFE SCIENCES FUND VI LPJun 2026 · 9 LPs$294.3MAUM

Source: SEC Form ADV Schedule D and EDGAR Form D filings. AUM is gross asset value as reported by the adviser.

Latest on 𝕏

F-Prime @fprimecapital

Nava Therapeutics is building next-gen lipid nanoparticles to do exactly that — targeting T cells, the kidney, and beyond. Proud to back the team as they emerge with $89M and head toward the clinic. 🧬 https://t.co/IVtAWuXrKC

Jul 15, 2026 · ♥ 3 · ⇄ 2

F-Prime @fprimecapital

AJ Loiacono spent years auditing PBM contracts and found a system obscuring costs rather than lowering them. His conclusion: real change would require rebuilding from within. In 2017, he did exactly that. Now @judihealth covers 58M+ lives. Full Q&A👉https://t.co/VyLpJohFgn

Jun 25, 2026 · ♥ 3

F-Prime @fprimecapital

F-Prime is honored to be named as a top investor for #GenAI & #mentalhealth in Galen Growth's 2024 report of the Health Tech 50 Core Investors. #HealthTech 50 report provides a deep dive into the top investors revolutionizing the digital health landscape: https://t.co/z2eNHLwEPf https://t.co/ObB1DmQaYp

Feb 6, 2025 · ♥ 9